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Microfluidic methods were applied to nucleic acid mutation identification and 
quantification. DNA melting analysis interrogation volumes were reduced 4 orders of 
magnitude (down to 1 nL volumes) from commercial instrumentation, allowing less 
reagent consumption while yielding adequate signal for genotyping and scanning of 
polymerase chain reaction (PCR) products. A microfluidic instrument was developed for 
digital PCR applications, using a spinning plastic disk patterned by xurography. The 
platform offers faster thermocycling times (30 cycles in ~12 min), simplified fluid 
partitioning, and a less expensive disposable when compared to currently available digital 
PCR platforms. PCR within the disk was validated by quantifying plasmid DNA sample 
using “on/off” fluorescence interrogation across 1000 wells (30 nL/well) at varying 
template concentration. A 94% PCR efficiency and product amplification specificity 
were determined by aggregate real-time PCR and melting analysis. The technique of 
quasi-digital PCR was also applied within this platform, wherein a single mutation copy 
was preferentially amplified from a large background of wild-type DNA, to detect and 
quantify low levels of rare mutations. This method demonstrated a sensitivity of 0.01% 
(detecting a mutant to wild-type DNA ratio of 43:450000), by mixing known 
concentrations of an oncogene mutation with thousands of wild-type template copies. 
Statistic analysis tools were constructed in order to interpret digital PCR data, with results 
comparing well to DNA absorption measurements. 
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The completion of the Human Genome Project in 2003 represents one of the 
largest single investigational projects ever completed and is a giant step to further 
understanding disease. This new knowledge should lead to large advancements in 
medicine and biotechnology, providing a more individualized approach to linking 
personal genetic profile to disease, if appropriate diagnostic and analysis tools can be 
created. Applications of molecular diagnostics include: identifying individuals with 
increased risk of developing certain disorders, screening populations for specific diseases, 
diagnosis, prognosis, personalized medicine, therapy response monitoring, forensics, 
identity testing, histocompatibility, veterinary testing, and environmental monitoring. 
Infectious disease testing (i.e., HIV, hepatitis C, hepatitis B, chlamydia, and gonorrhea) 
was the first molecular diagnostics segment explored and remains the largest market for 
molecular diagnostics. However, the emerging segments of oncologic, genetic, and 
pharmacogenomic testing are quickly gaining popularity and are the focus of this work.  
Microfluidics is still an emerging field but is gaining momentum and is starting to 
find its niche within molecular diagnostics. There is great appeal for sample-in, answer-
out tests, point-of-care testing for quick results, and more multiplexing, which may be 
made possible using microfluidics. Microfluidics has potential, yet unrealized, 
advantages as follows: low fluid volume consumption (i.e., less waste, lower reagent 
consumption, less sample needed), faster analysis (i.e., short diffusion distances, fast 
heating, small heat capacities), improved process control due to high surface-to-volume 
ratios, compact systems with combined functionality, precise volumetric control, 
potential for massive parallelization, enhancement of analytical performance, reduced 
fluid handling needs, and a low power consumption. Some disadvantages of 
microfluidics which have held back the technology to some degree include uniquely 
dominant physical and chemical effects (i.e., capillary forces, surface roughness, 
chemical interactions, and adsorption), lower signal-to-noise ratios, laminar flow which 
makes reagent mixing difficult, difficulty interfacing electronics and fluid interfaces with 
the macro-world, no direct sample-to-answer capabilities, and the fact that it is still a 
‘novel’ technology that has not been fully validated. 
This dissertation presents advancements of two related techniques within 
molecular diagnostics, the polymerase chain reaction (PCR) and DNA melting analysis, 
by applying microfluidics. A number of widely diverging topics and techniques are 
brought together in this dissertation. To aid the reader, terms related to these various 
topics and techniques are defined and their significance stated along with a brief literature 
review for each topic. The topics include variations on PCR and tools required for PCR 
analysis and mutation detection, circulating tumor cell biology, the importance of various 
genetic targets tested within this dissertation, and a microfluidic manufacturing 
technique. 
 
Polymerase Chain Reaction 
 
The polymerase chain reaction (PCR), discovered in 1984 by Kary Mullis and 
winner of a Nobel Prize, has become a gold standard in molecular biology (Mullis et al. 
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1986) and is the primary technique used in this dissertation. This technique allows a 
specific DNA segment to be amplified, creating millions of copies of a particular DNA 
sequence. PCR typically relies on a thermocycling process that denatures the DNA at a 
“high” temperature, and “cooler” temperatures allow enzymatic replication of the DNA 
sequence of interest. Primers, short oligonucleotide sequences (~20-25 base pairs), are 
designed complementary to the DNA and enable replication selectivity by framing the 
sequence to be replicated, facilitating polymerase binding. Variations from the basic PCR 
chemistry and fluorescent-based analysis methods have been conceived, with a few of 
these variations discussed hereafter. A wide variety of PCR uses have been developed 
including: sequencing (Wong et al. 1987; Ansorge 2009), gene expression analysis 
(Witsell et al. 1990; Thellin et al. 2009), diagnosis of hereditary diseases (Ballabio et al. 
1990; Lindeman et al. 1991), forensic science (Kasai et al. 1990; Morling 2009), 
detection of infectious disease (Vaira et al. 1990; Watzinger et al. 2006), and 
phylogenetics (Bhattacharya et al. 1993). 
 
Fluorescent DNA Dyes and Probes for PCR Product Analysis 
 
Detection of amplified DNA, both during and after PCR, is of critical importance 
in PCR analyses and in this work. Several fluorescent-based PCR product identification 
methods are available, with some of these methods being discussed within this section.  
Double-stranded DNA (dsDNA) fluorescent dyes are the most economical format 
for detecting, quantifying and determining PCR product genotypes. These dyes are 
saturating or intercalating dyes that bind to double-stranded DNA. Once bound, they 
fluoresce at a much higher intensity than in the unbound state when only single-stranded 
DNA is present. The disadvantage of dyes is that they will bind to any double-stranded 
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DNA in the reaction, including primer-dimers and other non-specific reaction products as 
well as certain hydrophobic proteins, thus requiring more optimization.  
Various probe methods have been implemented to increase product detection 
specificity. Probes fall into two general categories: labeled probes and unlabeled probes. 
TaqMan® (Heid et al. 1996), molecular beacons (Piatek et al. 1998), Scorpions™ 
(Whitcombe et al. 1999), and hybridization probes (Lay and Wittwer 1997; Livak et al. 
1995) are all labeled probe techniques. TaqMan® probes are oligonucleotides with a 
fluorescent reporter dye attached to the 5’ end and a quencher moiety coupled to the 3’ 
end. When unhybridized the proximity of the fluorophore and quencher molecules 
prevent fluorescent signal.  During PCR, when the polymerase replicates a template on 
which a TaqMan® probe is bound, the 5’ nuclease activity of the polymerase cleaves the 
probe to allow the fluorophore to fluoresce. Molecular beacons are similar to TaqMan® 
probes except they are designed to remain intact during amplification and must rebind to 
the target each cycle for signal measurement. Molecular beacons form a stem-loop 
structure when free in solution, bringing the fluorophore and quencher together to quench 
fluorescence. Scorpion™ probes use a single oligonucleotide that maintains a stem-loop 
configuration in the unhybridized state. The fluorophore is attached to the 5’ end and is 
quenched by a moiety coupled to the 3’ end. The 3’ portion of the stem also contains a 
sequence that is complementary to the extension product of the primer. After extension of 
the Scorpion™ primer, the specific probe sequence is able to bind to its complement 
within the extended amplicon thus opening up the hairpin loop. This prevents the 
fluorescence from being quenched and a signal is observed. Hybridization probes consist 
of two oligonucleotides that are each fluorescently labeled. One oligonucleotide has a 
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donor probe labeled at the 3’ end, absorbing excitation light. The other oligonucleotide 
has an acceptor probe on the 5’ end, adjacent to the donor probe, absorbing resonance 
energy emitted from the donor probe through the process of fluorescence resonance 
energy transfer (FRET). Therefore, fluorescence from the acceptor probe will only occur 
when both the donor and acceptor probes have annealed to the PCR product. One 
downside to labeled probes is that they are expensive to synthesize and thus drive up 
PCR cost. 
Luna Probes® (Zhou et al. 2004; Erali et al. 2008), and snapback primers (Zhou 
et al. 2008) are unlabeled probe techniques that are much less expensive than labeled 
probes and take advantage of double-stranded dyes combined with melting analysis to 
provide specificity.  Asymmetric PCR is typically performed to improve the signal-to-
noise ratio of the unlabeled probe. A Luna Probe® consists of a 3’-blocked 
oligonulceotide sequence designed to overlay the mutation site of interest. The melting 
temperature (Tm) of the unlabeled probe is lower than the PCR amplicon and its melting 
curve is used to genotype the mutation site by either Tm or melting curve shape. A 
snapback primer includes a 5’ tail complementary to its extension product with the tail 
“snapping back” to overlay the mutation site with a lower Tm than the PCR amplicon. 





Asymmetric PCR allows one strand of the DNA double helix to be preferentially 
amplified more than the other by using unequal concentrations of forward and reverse 
primers during PCR and is a useful technique used for mutation identification in Chapters 
5
4 and 6 of this dissertation.  This method generally uses more temperature cycles than 
symmetric PCR (Montgomery et al. 2007) because amplification becomes linear after the 
limiting primer is exhausted.  LATE-PCR has been introduced to improve this efficiency 
by changing primer design based on primer-target hybridization (Sanchez et al. 2004).  
Asymmetric PCR takes advantage of the excess strand amplified and increases visibility 
of the probe-amplicon duplex melting transition by limiting the fluorescent signal of the 
amplicon while increasing the fluorescent signal of the probe.  
 
Quantitative Real-Time PCR (qPCR) 
 
PCR instruments today commonly provide real-time fluorescent signal 
acquisition. Fluorescent signal, from either dsDNA dye or labeled probes, is measured 
after each PCR cycle, with the fluorescent intensity increasing proportional to the number 
of PCR amplicons created. Measuring the process in real-time provides an analog method 
of quantifying the amount of starting DNA template (Higuchi et al. 1992; Higuchi et al. 
1993; Wittwer et al. 1997). This method is used in Chapter 5 of this dissertation to 
validate digital PCR results and PCR efficiency within our spinning disk platform. A 
threshold is set at a level that reflects a statistically significant increase over the 
calculated baseline signal, distinguishing baseline fluorescent signal from amplification 
signal. The cycle at which the PCR reaches the threshold value is the quantification cycle 
(Cq) (Bustin et al. 2009). The Cq value will shift depending on the number of starting 
DNA templates. Positive and negative controls and/or calibration curves are used. This 
method of quantification relies on consistent PCR efficiencies, fluorescent signal fidelity 





The term “digital PCR” was first coined in 1999 by Vogelstein (Vogelstein and 
Kinzler 1999).  Limiting dilution was used to detect a minor fraction of altered DNA by 
diluting to the point of having only one DNA template in a given reaction volume.  The 
PCR was then run with molecular beacon probes in solution.  Once amplified, the 
reaction volumes were fluorescently analyzed; wild-type and mutated DNA were then 
quantified by relying on binary positive/negative calls.  Recently, the concept of digital 
PCR has been miniaturized using microfluidics to limit the amount of DNA template 
rather than dilutions.  One of the first microfluidic applications presented was multigene 
analysis of environmental bacteria using multiplex digital PCR (Ottesen et al. 2006).  
Quantitative population analysis of transcription factor expression was also initially 
shown (Warren et al. 2006).  Each of these microfluidic applications uses Fluidigm’s 
Digital Array chip.  Fluid is distributed into parallel dead-end channels using pneumatic 
pressure.  A comb valve is then actuated, deflecting a membrane down to section off 
thousands of isolated nanoliter-sized reaction chambers.  This chip is then thermocycled 
and analyzed using a microarray scanner. One group has even investigated digital PCR 
down to picoliter-sized reaction volumes using a microdroplet-based system (Beer et al. 
2007; Beer et al. 2008; Kiss et al. 2008). This method is capable of creating thousands to 
millions of droplets for digital PCR analysis. The statistical data acquired are superior to 
current approaches but the instrumentation and chemistry are complex and expensive.  
This dissertation presents a novel microfluidic digital PCR platform using a 
spinning disk to passively partition a sample into individual reactions to improve upon 
these existing methods. Applications of digital PCR include identification of rare 
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mutations within an excess of normal DNA (Yung et al. 2009), assessing allelic 
imbalance (Fan and Quake 2007; Fan et al. 2009), copy number variation (Qin et al. 
2008), viral load (McMahon et al. 2008), non-invasive prenatal testing (Lun et al. 2008), 
haplotyping (Menzel et al. 2009) and aiding in next-generation sequencing (White III et 




Amplification refractory mutation system (ARMS) PCR (Newton et al. 1989) is 
an allele-specific amplification process that allows single nucleotide polymorphism 
(SNP) detection at a specific locus. This technique implements a primer with a terminal 
3’-nucleotide that is allele-specific.  Therefore, one can design this primer to either match 
the ‘mutant’ template or match the ‘normal’ template and be refractory to the mismatch, 




Allele-specific competitive blocker-polymerase chain reaction (ACB-PCR) was 
first introduced in 1995 (Orou et al. 1995), providing a “double-kill” method to 
preferentially amplify either mutant or normal template, thus improving ARMS PCR. A 
probe is designed to match the template to be suppressed during PCR. Thus, the 
mismatched ARMS primer is not only refractory to the template but also has to compete 
with the probe to anneal to the template. ACB-PCR greatly delays PCR of the mismatch 
but also delays the Cq of the matched template.  Zhou and Wittwer, at the University of 
Utah, have adapted this method and used the probe as an indicator as well as a blocker, 
using asymmetric PCR combined with DNA melting analysis to semi-quantify the 
8
number of mutant DNA copies present within a pool of normal DNA. This method is 
capable of reaching sensitivity limits of one mutation copy in as many as 100000 wild 




This approach combines digital PCR with ACB-PCR to provide ultra-sensitive 
detection and quantification of rare nucleic acid mutations and is the method used in 
Chapter 6 of this dissertation. It is termed quasi-digital because each well is loaded with 
multiple copies of wild-type DNA but contains at most one copy of mutation template.  
Parallel ACB-PCR reactions are performed followed by fluorescence detection to 
determine how many reactions contain a mutation copy, counting the mutations digitally, 
for improved quantification over real-time PCR methods. Parallel ACB-PCR reactions 





Multiplex PCR was first introduced in 1988 for use in identifying exon deletions 
simultaneously (Chamberlain et al. 1988).  This technique is powerful because it allows 
multiple DNA sites, physically separated by large distances, to be investigated 
simultaneously.  Multiple unique sets of primers are designed to amplify the specific 
DNA sites desired, which requires careful primer design so as to reduce any nonspecific 
amplification during PCR (Elnifro et al. 2000).  Fluorescently-labeled multicolor probes 
can be used to distinguish each site. Alternatively, a saturating dye can interrogate 
multiple mutations by observing their melting temperature and melting shapes (Bernard 
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et al. 1998; Erali et al. 2006). This concept is suggested for future work based on our 
digital PCR platform. 
 
DNA Melting Analysis 
 
DNA melting analysis was introduced in 1997 as a method to analyze PCR 
product (Ririe et al. 1997), and represents the genotyping and scanning methods used 
throughout this dissertation. Typically, a double-stranded intercalating fluorescent dye is 
included in the PCR (Wittwer et al. 2003). Following amplification, the temperature of 
the double-stranded DNA product is raised slowly while fluorescence is continuously 
monitored. When the double helix denatures or ‘melts’ the fluorescence rapidly 
decreases. The melting temperature or Tm of the product is defined as the temperature at 
which half of the DNA product has denatured. When using this method, homozygous 
changes cause the absolute Tm to shift (Liew et al. 2004) while heterozygous changes 
alter melting curve shape (Reed et al. 2004; Hermann et al. 2006). DNA melting analysis 
provides a rapid solution that reduces complexity and contamination risk as compared to 
other DNA analysis methods (Zhou et al. 2004).  
Analysis of the PCR product melting transition often provides adequate 
genotyping results. However, probe techniques combined with asymmetric PCR can 
provide even greater specificity (Zhou et al. 2005).  Chapters 2 and 3 show that DNA 
melting analysis is capable of being miniaturized down to nanoliter interrogation volumes 





Circulating Tumor Cells 
The discovery of circulating tumor cells (CTCs) in peripheral blood was first 
made in 1869 by T.R. Ashworth (Ashworth 1869). This discovery provided the ground 
work for the ‘seed and soil’ theory of metastasis, presented in 1889 by Stephen Paget 
(Paget 1889), which still stands today (Fidler 2003). This theory hypothesizes that tumor 
cells (the ‘seed’) can migrate to and implant themselves in other organs that contain the 
proper microenvironment for proliferation (the ‘soil’).  
Detecting and quantifying CTCs has the potential of providing a non-invasive 
technique for 1) diagnosing cancer earlier, 2) deciding the most appropriate therapy, 3) 
monitoring therapy response, and 4) determining drug resistance. The challenge with this 
method arises from the low concentration of CTCs, which can be as low as 1 cell in 1 ml 
of blood (Nagrath et al. 2007), or one tumor cell per 105 - 107 peripheral blood 
mononuclear cells (Ross et al. 1993), making it difficult to detect and quantify these 
cancer cells with currently available techniques. Some enrichment techniques have been 
developed to address the challenge of low CTC concentrations, such as filtration (Vona et 
al. 2000), density gradient (Müller et al. 2005), flow cytometry (Cruz et al. 2005) and 
immunomagnetic enrichment (Allard et al. 2004). However, these techniques have been 
shown to suffer from low specificity, low sensitivity, a loss of CTCs, or false negatives 
and positives (Alunni-Fabbroni and Sandri 2010). In order to overcome these issues this 












V-raf murine sarcoma viral oncogene homolog B1 is a protein encoded by the 
BRAF gene and is involved in sending signals in cells, affecting cell division, 
differentiation, and secretion. This gene can be mutated in many cancers, which can 
cause an increase in growth and the spread of cancer cells. BRAF mutations have been 
identified in 66% of malignant melanomas (Davies et al. 2002) and at a lower frequency 
in a wide range of human cancers including colorectal cancers, liver cancers, lung 
cancers, breast cancers, papillary thyroid carcinoma, etc. (Namba et al. 2003). The BRAF 
T1796A mutation accounts for approximately 92% of BRAF mutations in melanoma 




A “DNA toolbox” was reported in 1999 to aid in characterization of mutation 
scanning methods (Highsmith Jr. et al. 1999). The toolbox consists of highly 
characterized plasmid constructs that contain inserts of 800-1000 bp with GC contents of 
40, 50, or 60%. At a central position of the insert are the four possible nucleotide bases. 
This tool allows one to determine the effects of GC content, nucleotide substitution, PCR 




Warfarin is a commonly used coumadin anticoagulant with wide inter-individual 
dosage variation.  Variants in the VKORC1 and CYP2C9 genes and patients’ age and 
height account for 50-60% of the dosage variation (Sconce et al. 2005; Wadelius et al. 
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2007).  Warfarin interferes with vitamin K recycling in the liver and the VKORC1 gene is 
what regulates the main protein in the vitamin K epoxide reductase complex.  Warfarin is 
metabolized by cytochrome P450 2C9 (CYP2C9), with CYP2C9 *2 and *3 alleles 





  Mutations within the CFTR gene have been found to cause cystic fibrosis, a 
disease that causes the body to produce thick, sticky mucus which causes difficulty 
breathing and insufficient enzyme production in the pancreas.  This disease is one of the 
most common autosomal recessive genetic disorders among the Caucasian population, 
affecting approximately 1 in 3,300 with a carrier rate of 1 in 29 (Heaney et al. 2006).  A 
3-bp deletion (delta F508 deletion) within this gene is the most common mutation 




Ataxia-telangiectasia is an autosomal recessive disorder which may include 
cerebellar degeneration, immunodeficiency, chromosomal instability, radiosensitivity and 
a predisposition for cancer (Platzer et al. 1997).  This disorder occurs in about 1 in 40,000 





Hemochromatosis is an autosomal recessive disorder of iron metabolism causing 
the body to accumulate iron and affects between 1 in 200 to 1 in 400 individuals (Feder et 
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al. 1996).  This excess iron can lead to failure of a variety of organs and can also cause 
cirrhosis, hepatomas, diabetes, cardiomyopathy and arthritis (Andrews 1999).  The major 
gene correlated with hemochromatosis is HFE.  
 
Xurography Rapid Prototyping 
 
Cutting plotters are frequently used in the graphic design industry, typically 
patterning designs out of adhesive-backed materials for signs or other artwork. Many 
cutting plotters provide good mechanical resolution, with some offering a step size as low 
as 5 μm. The first use of this technology for microfluidic fabrication came in early 2005, 
in which Treise et al. used a cutting plotter to pattern channels in a vinyl film and then 
sandwiched the patterned layer between two sheets of Plexiglas, with inlet and outlet 
holes (Treise et al. 2005). Later that same year, Bartholomeusz et al. extensively 
evaluated this microfabrication process, using multiple materials and techniques 
(Bartholomeusz et al. 2005). This group coined the cutting plotter method xurography, 
using the Greek root words xuron and graphe, which mean razor and writing, 
respectively. This prototyping method can provide a very short turnaround time; 
microdevices can be designed, fabricated, and tested within the same day. The process of 
xurography is used throughout this dissertation. 
The feature sizes that xurography can provide depend on several factors. The 
minimum step size of stepper motors within the cutting plotter, blade sharpness, blade 
angle, material properties of the substrate, cutting speed, cutting force, and cutting mode 
all help determine the smallest features possible (Gale et al. 2008). Xurography has been 
used in shadow masks (Kim et al. 2006), electroplated microchannels (Bartholomeusz et 
al. 2005), micromolding (Kim and Gale 2005), laminated microfluidic structures 
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(Sundberg et al. 2010), and double-layer adhesive materials (Greer et al. 2007; Sundberg 
et al. 2007; Crews et al. 2009).  
 CO2 laser micromachining provides a similar manufacturing method to 
xurography in that both provide a material removal process (Klank et al. 2002). In fact, 
CO2 lasers have been shown to effectively pattern double-sided tape (Luo et al. 2007), 
just as with the work discussed in Chapters 2 and 3 of this dissertation for patterning tape 
by xurography. The primary disadvantage of using a CO2 laser is that the upfront 
equipment cost is an order of magnitude higher than for that of a cutting plotter. Another 
disadvantage is that the material to be ablated or machined must match well with the 
wavelength of the laser, otherwise the substrate may char, melt or not machine at all. It 
can be complex to optimize parameters of a laser system, as one must consider pulses per 
inch, pulse frequency, power, focal distance, number of passes, and the beam velocity 
(Liu and Gong 2009). With a cutting plotter the primary parameters are blade speed and 
force, although other parameters can also affect the quality of the cut to a lesser degree. 
However, due to the various controllable parameters of a laser system much thicker 
substrates can be machined and depth of cut can be controlled to ablate features into the 
substrate, rather than solely relying on the substrate thickness for depth (Snakenborg et 
al. 2004). Smaller feature sizes can be obtained by focusing the beam spot size and more 
intricate and precise cutting is available due to the fact that a blade does not have to be 
dragged through the material. The cutting speed of a pattern can be increased as well, so 








The overarching theme of this dissertation is applying microfluidic techniques to 
DNA mutation analysis in order to reduce the cost of tests and, in the final chapters, to 
also improve low-level mutation quantification using a thousand simultaneous reactions 
and a quasi-digital quantification method. Chapter 2 looks at signal-to-noise ratio 
reduction as the technique of DNA melting analysis is miniaturized in microfluidics using 
three different mutation sites to provide data. This chapter is published in its entirety in 
the peer-reviewed journal Biomedical Microdevices (Sundberg et al. 2007). Chapter 3 
compares two microfluidic chip fabrication techniques, traditional glass etching and 
xurography rapid prototyping, using the application of DNA melting analysis as the data 
for comparison. This chapter is published in its entirety in the peer-reviewed Journal of 
Micromechanics and Microengineering (Greer et al. 2007). Chapter 4 is a 
pharmacogenomic application of microfluidic DNA melting analysis using three genes 
involved with warfarin drug dosing. The chapter is published as an extended abstract 
within the American Institute of Chemical Engineers (AIChE) Annual Meeting 
conference proceedings (Sundberg et al. 2007). Chapter 5 presents a novel disk design 
and instrument for microfluidic digital PCR. This chapter is published in the peer-
reviewed journal Analytical Chemistry and includes a Supplementary Information section 
(Sundberg et al. 2010).  Chapter 6 applies the work presented in Chapter 5 to improve the 
limits of detection for cancer mutation screening. This chapter will be submitted to the 
peer-reviewed journal Analytical Biochemistry. Chapter 7 provides statistical analysis of 
the digital PCR disk, providing Poisson distributions and confidence intervals. Lastly, 
16
Chapter 8 provides a conclusion to our microfluidic DNA mutation analysis, presenting 
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Abstract Solution-phase, DNA melting analysis for het-
erozygote scanning and single nucleotide polymorphism
(SNP) genotyping was performed in 10 nl volumes on a cus-
tom microchip. Human genomic DNA was PCR ampliﬁed
in the presence of the saturating ﬂuorescent dye, LCGreen r©
Plus, and placed within microﬂuidic channels that were cre-
ated between two glass slides. The microchip was heated at
0.1◦C/s with a Peltier device and viewed with an inverted
ﬂuorescence microscope modiﬁed for photomulitiplier tube
detection. The melting data was normalized and the neg-
ative ﬁrst derivative plotted against temperature. Mutation
scanning for heterozygotes was easily performed by com-
paring the shape of the melting curve to homozygous stan-
dards. Genotyping of homozygotes by melting temperature
(Tm) required absolute temperature comparisons. Mutation
scanning of ATM exon 17 and CFTR exon 10 identiﬁed
single base change heterozygotes in 84 and 201 base-pair
(bp) products, respectively. All genotypes at HFE C282Y
were distinguished by simple melting analysis of a 40-bp
fragment. Sequential analysis of the same sample on the
gold-standard, commercial high-resolution melting instru-
ment HR-1TM, followed by melting in a 10 nl reaction cham-
ber, produced similar results. DNA melting analysis requires
only minutes after PCR and is a simple method for genotyp-
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ing and scanning that can be reduced to nanoliter volumes.
Microscale systems for performing DNA melting reduce the
reagents/DNA template required with a promise for high
throughput analysis in a closed chamber without risk of con-
tamination.
Keywords DNA melting . Mutation scanning . SNP
genotyping . Xurography
Introduction
Microsystem technology has generated tremendous inter-
est recently for use in clinical diagnostics and forensics
(Verpoorte, 2002). One of the most important analytical
tools, the polymerase chain reaction (PCR) (Saiki et al.,
1985), can amplify a short region of DNA over 106-fold in
10–15 min (Wittwer et al., 1990). Several groups have devel-
opedmicrosystems for performing PCR in nanoliter volumes
(Gulliksen et al., 2004; Hu¨hmer and Landers, 2000; Ibrahim
et al., 1998; Khandurina et al., 2000; Liu et al., 2002; Yoon
et al., 2002), including one group with volumes as small as
86 pl (Nagai et al., 2001). Advantages of microscale PCR in-
clude lower reagent and target DNA consumption and better
heat transfer rates for faster reaction times during thermocy-
cling. After PCR ampliﬁcation, many analytical techniques
are available for detecting sequence variants, including sim-
ple size separation on a gel matrix and complex mass spec-
trometry methods. Some of these methods have been incor-
porated into microsystems; for example, PCR followed by
electrophoretic separation (Waters et al., 1998; Lagally et al.,
2001). However, the fabrication of the chip and integration
of the detection method may become complicated.
DNA melting analysis as a complement to PCR was
introduced in 1997 (Ririe et al., 1997). A dye is included in
Springer
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the PCR that ﬂuoresces in the presence of double-stranded
DNA, but not single-stranded DNA. After ampliﬁcation,
ﬂuorescence is monitored as the double-stranded DNA
product is slowly heated. When the double helix melts,
ﬂuorescence rapidly decreases. The negative ﬁrst derivative
of ﬂuorescence with respect to temperature shows the
melting temperature (Tm) as maxima. Recent advances in
melting analysis instrumentation (Herrmann et al., 2006) and
saturating DNA dyes (Wittwer et al., 2003) allow detection
and genotyping of single nucleotide polymorphisms (SNPs).
If the change is heterozygous, DNA heteroduplexes alter the
shape of the melting curve, providing a simple method for
mutation scanning (Reed and Wittwer, 2004). If the change
is homozygous, the absolute temperature of the melting tran-
sition shifts (Liew et al., 2004). DNA melting analysis, when
compared to existing PCR analytical techniques, is advanta-
geous because it is less complicated, faster (less than 20 min
for PCR and analysis), and prevents contamination of the
sample and environment due to its closed-tube format (Zhou
et al., 2004). The speciﬁc dye used determines the capabil-
ities of the method; LCGreen r© Plus detects heterozygotes
well and does not inhibit PCR (Wittwer et al., 2003).
DNA melting analysis has been previously reported in
microscale systems with oligonucleotides attached to the
chip surface (Dodge et al., 2004). However, immobilization
of oligonucleotides adds additional complexity and cost to
the fabrication of the chip. Furthermore, hybridization to
immobilized probes takes signiﬁcantly longer than solution-
phase hybridization and is limited by steric factors and
mass transport conditions. By monitoring solution-phase
melting analysis on a microchip, the complexity of chip
fabrication and analysis time are minimized. Using custom
instrumentation and microchannel chips, we demonstrate
solution-phase mutation scanning and SNP genotyping in
10 nl reaction volumes using three different genomic DNA
targets. To the best of our knowledge this is the ﬁrst time that




The microchips were manufactured using Xurography
(Bartholomeusz et al., 2005). The process uses Adobe
Illustrator r© (Adobe, San Jose, CA) to generate the geometry
of the channel structures. The output ﬁles are exported to a
knife plotter (Graphtec, Irvine, CA) which cuts the channel
and well structures out of a 25 μm thick, double coated tape
(9019, 3M, St. Paul, MN) consisting primarily of polyethy-
lene terephthalate (PET), a material used with PCR in previ-
ous research (Northrup et al., 1993). Input and output ports,
Fig. 1 Dimensioned sketch of the double coated tape cut with the
knife plotter. The sketch is not to scale
melting analysis wells, and connecting channels were de-
signed as shown in Fig. 1. The channels had a cross section
of 175 × 25μm. The melting analysis wells had a diameter
of 715 μm and a total volume of 10 nl. The patterned tape
was then sandwiched between two 25 × 75mm glass slides.
One of the glass slides had 2 mm diameter holes located at
the input and output ports of the channel. A NanoPortTM
assembly (Upchurch Scientiﬁc, Oak Harbor, WA) was then
attached to the outlet port on the glass slide with a luer lock
attachment. The input port was placed 22.5 mm from the
center of the DNA analysis chamber and was used for load-
ing the sample. A syringe was connected to the luer ﬁtting
at the outlet port and was used to create a vacuum and draw
the sample through the channel into the analysis chamber.
Figure 2 shows a photograph of the entire assembly (A), a
photograph of the 10 nl well (B), and a cross-section sketch
of the assembled microchip (C).
Fluorescence detection
Figure 3 shows a sketch of the modiﬁed inverted microscope
used for ﬂuorescent interrogation of the microchip. For
excitation, the output of a mercury arc lamp (HBO 50 W,
Carl Zeiss, Thornwood, NY) was passed through two neutral
density ﬁlters (ND-1, Edmund Optics, Barrington, NJ) in
series to limit the light intensity, unless otherwise speciﬁed.
The light passed through an excitation bandpass ﬁlter
(426–446 nm, Chroma Technology Corp., Rockingham,
VT), was reﬂected at 45◦ by a dichroic beam splitter (455 nm
long-pass, Chroma Technology Corp.), and focused onto the
analysis chamber by a 20× objective (Ph2 Achrostigmat,
NA = 0.45, Carl Zeiss). Emitted light was then collected
through the same lens, passed through the dichroic beam
splitter and an emission bandpass ﬁlter (460–500 nm,
Chroma Technology Corp.). Optic ﬁlters were designed
to match LCGreen r© Plus (Herrmann et al., 2006). The
collimated light was focused onto the end of a ﬁber optic
cable (400 μm diameter UV/VIS range, CVI Spectral
Products, Putnam, CT) with a lens of focal length 12.6 mm
and diameter 25.4 mm (AT-SHL-9, CVI Spectral Products).
The ﬁber optic was connected to a photomultiplier tube
(PMT) module (714 Photomultiplier Detection System,
Photon Technology International, Birmingham, NJ) with
Springer
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Fig. 2 (A). Photograph of the microchannel assembly with the entire chip being 25 × 75 mm. (B) Photograph of the 10 nl well with a wall height
of 25 μm. (C) A cross-section sketch of the microchip at the 10 nl well. The sketch is not to scale
Fig. 3 Sketch of the optics set-up used in the modiﬁed inverted mi-
croscope
an R1527 PMT (Hamamatsu, Bridgewater, NJ). The analog
output of the PMT module was input to a data acquisition
(DAQ) card (PCI-MIO-16XE-10, National Instruments,
Austin, TX) and analyzed with LabView 7.1 (National
Instruments) on a personal computer. Figure 4 shows a
diagram (A), and a photograph (B) of the custom system.
Temperature control
A 15 × 15 × 3.2 mm Peltier heater (TZ13153-03, Mel-
cor, Trenton, NJ) contacted the glass slide directly above the
interrogation well through a Zinc Oxide/Silicone based heat
sink compound (TG-001, Melcor). A 7.5 × 3.5 × 3.5 cm
steel block was placed on top of the heater as a heat sink. A J-
type thermocouple (TT-J-40-50, Omega, Stamford, CT) was
clamped, using a toothless alligator clip andKapton tape, into
a 2 mm diameter hole, drilled approximately 2–3 mm to the
side of the analysis well, ﬁlledwith heat sink compound (Fig.
2(C)). The signal from the thermocouple was ampliﬁed and
linearized (AD594, Analog Devices, Norwood, MA) and the
ouput was connected through a shielded I/O connector block
(SCB-68, National Instruments) to the PCI-MIO-16XE-10
DAQ card. The temperature measurement was calibrated us-
ing a Fluke thermometer (54 II Thermometer, Fluke, Everett,
WA) to within ± 0.3◦C at 50◦C. Heating control was imple-
mented using an analog output from a PCI-6014 DAQ card
(National Instruments) connected to a shielded connector
block (BNC-2110, National Instruments) that controlled a
power supply (Zero-Up, Lamda Instruments, Neptune, NJ)
connected to the Peltier device. A 550 mV input to the power
supply was increased by 0.83 mV/s, resulting in a heating
rate of 0.1◦C/s over the temperature range of 65–85◦C.
Sample preparation
Rapid cycle PCR was performed in a LightCycler r© (Roche
Applied Science, Indianapolis, IN) with programmed transi-
tion rates of 20◦C/s. Each 10 μl mixture consisted of 50 ng
of genomic DNA as the template, 0.5 μM of each primer,
200μMof each deoxynucleotide triphosphate (dNTP), 0.4U
ofKlenTaq1 polymerase (ABPeptides, St. Louis,MO), 88 ng
of TaqStart antibody (ClonTech,Mountain View, CA), 2 mM
MgCl2, and 1× LCGreen Plus (Idaho Technology, Salt Lake
City,UT) in 50mMTris (pH8.3) and 500 ng/μl bovine serum
albumin (BSA). Genotyped human genomic DNA was ob-
tained from Coriell Cell Repositories (Camden, NJ) for the
ATM exon 17 and HFE C282Y DNA templates. For CFTR
exon 10, genomic DNA was isolated and puriﬁed using the
PuregeneTM Genomic DNA Puriﬁcation Kit (Gentra Sys-
tems, Minneapolis, MN) according to its standard protocol
for 3 ml whole blood. The DNA concentration was then de-
termined by absorbance at 260 nm (A260), assuming an A260
of 1.0 is 50 ng/μl. The purity, according to the A260/A280 ab-
sorption ratio, for all DNA templates was a minimum of 1.8.
Three different DNA targets were analyzed, two for
mutation scanning and one for SNP genotyping. The ATM
exon 17 PCR product (Genbank Acc.# NM 000051) (Kastan
and Lim, 2000) was 84 base-pairs (bp) in length (5′-
TGTCCTTTAGGGCAGCTGATATTCGGAGGAAATTG
TTAATC/ATTAATTGATTCTAGCACGCTAGAACCTAC
CAAATCCCTCCACC-3′) with the SNP indicated in bold. It
was ampliﬁed with primers 5′-TGTCCTTTAGGGCAGCT
GAT-3′ and 5′-GGTGGAGGGATTTGGTAGGT-3′ by 30
temperature cycles of 95◦C with a 0 s hold, 55◦C with a 0 s
hold, and 72◦C with a 3 s hold.
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Fig. 4 (A). Diagram of the modiﬁed inverted microscope. (B) Photo-
graph of the system with: (1) DAQ Cards; (2) Thermocouple assembly;
(3) Photomultiplier assembly; (4)Microchipwith thermocouple, Peltier
heater, and heat sink; (5) Light source; (6) Excitation and emission ﬁl-
ters and objective lens
The CFTR exon 10 PCR product (Gen-






ACTAGAAGAGGTAAGAAACTATGT-3′) with the 3-bp
deletion F508del (Du et al., 2005) in bold. It was ampliﬁed
with primers 5′-ACTTCTAATGGTGATTATGGG-3′ and
5′-ACATAGTTTCTTACCTCTTC-3′ after a 5 s denaturation
at 95◦C with 33 temperature cycles of 95◦C with a 0 s hold,
54◦C with a 0 s hold, and 72◦C with a 4 s hold.
The HFE C282Y PCR product (Genbank Acc.#
Z92910) (Settin et al., 2006) was 40-bp in length
(5′-TGGGGAAGAGCAGAGATATACGTG/ACCAGGTGG
AGCACCCA-3′) with the SNP in bold. It was ampliﬁed
with primers 5′-TGGGGAAGAGCAGAGATATAC-3′ and
5′-TGGGTGCTCCACCTG-3′ after denaturation for 5 s at
95◦C with 29 temperature cycles of 94◦C with a 0 s hold,
55◦C with a 1 s hold, and 72◦C with a 1 s hold. For melting
analysis of C282Y, one of the ND = 1.0 ﬁlters was replaced
with a ND = 0.5 ﬁlter.
Microchip preparation
In order to prevent cross-contamination between samples, the
microchannels were cleansed with DNA AwayTM (Molecu-
lar BioProducts, San Diego, CA), ﬂushed with DI water, and
then coated with BSA (Al-Soud and Radstrom, 2001), at
a concentration of 2.5 mg/ml, before each run. One chan-
nel was used for all genotypes of ATM exon 17 and one
channel was used for HFE C282Y targets, allowing opti-
mal temperature reproducibility between genotypes. CFTR
exon 10 used two chips, one for each of the genotypes
tested.
Melting curve acquisition and analysis
After ampliﬁcation, the LightCycler capillary was trans-
ferred to an HR-1TM instrument (Idaho Technology) and
heated at 0.1◦C/s for a high-resolution reference melting
curve. The sample was then spun out of the capillary into
a microfuge tube and one μl of sample was injected into
the channel inlet port using a micro-pipette. A syringe on
the outlet port was used to pull the sample into the channel.
The x and y-axis stage of the inverted ﬂuorescent microscope
(Axiovert 100, Carl Zeiss) was used to align the 10 nl well
with the optics and the z-axis was used for focus. The sam-
ple was heated at 0.1◦C/s with 20 data points acquired every
1◦C. At least three melting curves were obtained for each
genotype.
HR-1 and microchip melting data were analyzed using
custom software written in LabView as previously described
(Gundry et al., 2003; Wittwer et al., 2003). Fluorescence
intensity values were normalized between 0 and 100% by
deﬁning linear baselines before and after the melting transi-
tion of each sample. Negative derivative plots for each curve
were calculated using Savitsky-Golay (Press et al., 1992)
polynomials of the second-degree at each point with a 33–
40 point window for the microchip data. For data from the
HR-1, a window of 60–90 points was used. The normalized
melting curves reported for CFTR exon 10 had the tempera-
ture axis of each curve adjusted to superimpose each of the
curves over a speciﬁed ﬂuorescence interval, as described
previously (Wittwer et al., 2003). Temperature axis adjust-
ment allowed shape distinction between the two genotypes
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tested. Signal-to-noise ratios (S/N) were calculated, as de-
scribed previously (Herrmann et al., 2006).
Results and discussion
Solution-phase mutation scanning and SNP genotyping with
DNA dyes can be performed within a microchip at a
thousand-fold reduction in analysis volume from current sys-
tems. Complete genotyping at the C282Y locuswas achieved
with both homozygotes and the heterozygote easily differen-
tiated. For scanning, a SNP heterozygote was detectedwithin
ATM exon 17 and a 3-bp deletion within CFTR exon 10. Mu-
tation scanning is a process used to scan for mutations within
a targeted region of DNA. Heterozygotes were easily iden-
tiﬁed for the known targets analyzed. Further study of pre-
viously unknown mutations would be necessary to establish
the sensitivity and speciﬁcity of the method. These meth-
ods do not require any sample processing, electrophoretic
separation, labeled probes, real-time PCR or allele-speciﬁc
ampliﬁcation.
Figure 5 shows derivative melting plots of normal and
heterozygous DNA for a SNP within an 84-bp fragment of
ATM exon 17. Panel (A) shows results from a 10 nl sam-
ple using the microchip system, in good agreement with
panel (B), the HR-1 instrument with a 10 μl sample volume.
The HR-1 instrument is the gold standard for high-resolution
melting analysis with an absolute temperature standard devi-
ation < 0.02◦C and 200 data points for every 1◦C (Herrmann
et al., 2006). In both systems, there is a clear distinction be-
tween heterozygous and homozygous products, observed as
a change in curve shape. This shape change occurs because
of the contribution of heteroduplexes to the overall melting
curve as previously described (Gundry et al., 2003; Wittwer
et al., 2003). Similarly, Fig. 6 shows ten derivative melt-
ing plots of both normal and heterozygous DNA for a 3-bp
deletion within a 201-bp fragment of CFTR exon 10. The
10 nl volume plot (A) again shows good agreement with
the 10 μl plot (B) and in both instruments, heterozygotes
are clearly identiﬁed. The normalized and temperature axis
adjusted melting curves showed a distinction by shape of
the normal and heterozygous samples within the 10 nl plot
(C) and the 10 μl plot (D). It is noted that the temperature
variation between chips is large for this target yet the shape
of the curves were all distinguishable, thus allowing correct
detection of mutations for the 20 samples analyzed.
Figure 7 shows full genotyping at the C282Y locus of
HFE. Again, the microchip data in (A) is very similar to the
HR-1 data in (B). Heterozygous melting curves show the
characteristic shape change resulting from heteroduplexes.
Wild-type and mutant homozygotes are distinguished by
their Tms, with the mutant allele about 2◦C lower than the
wild-type allele.
Fig. 5 Negative derivative plots for the microchip (A: 10 nl) and the
HR-1 (B: 10 μl) using the ATM exon 17 target. Homozygous wild-type
template (red line); heterozygous mutant template (black line)
Table 1 lists the S/N and Tms for each genotype in both
instruments. Even though the reaction volume is decreased
by three orders of magnitude, the S/N for the microchip is
only 1.5 orders of magnitude less than that of the HR-1.
As can be seen from Figs. 5–7, the microchip S/N is ade-
quate for both mutation scanning and genotyping. Tms were
similar on both instruments, although differences between
0.2–1.6◦C were observed. These shifts were speciﬁc to each
microchip studied and are explained by the thermal gradi-
ent across the Peltier heater (0.3–0.4◦C/mm) and variation
in the thermocouple placement relative to the analysis well
(0.1–0.4 mm). A larger Peltier device and/or addition of a
conducting plate between the heater and the melting chip
should distribute heat more evenly. Broader melting transi-
tions of the negative derivative plots were observed on the
microchip relative to the HR-1 (Figs. 5–7). This broadening
is an artifact of the Savitsky–Golay polynomials, due to the
fact that fewer points were ﬁtted for the microchip plots.
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Fig. 6 Negative derivative plots for the microchip (A: 10 nl) and
the HR-1 (B: 10 μl) using the CFTR exon 10 target. Homozygous
wild-type template (red line); heterozygous mutant template (black
line). Normalized and temperature axis shifted melting plots for the
microchip (C: 10 nl) and the HR-1 (D: 10 μl) using the CFTR exon
10 target. Homozygous wild-type template (gray lines); heterozygous
mutant template (black lines)
Figure 6(C) and (D) indeed show that the slopes of the melt-
ing curves between the microchip and HR-1 are very similar.
The Xurography microchip manufacturing process was
appealing because it did not require clean room techniques,
thus lowering manufacturing costs, and the fabrication was
quite rapid (a microchip could be built and DNA tests per-
formed within a working day). One other group has pre-
viously reported the use of this manufacturing technique,
fabricating a DNA extraction microchip (Kim et al., 2005).
Using Xurography, a microchip channel design was cut out
of an adhesive-backed plastic and placed within a Petri dish
to create a polydimethylsiloxane (PDMS) mold. The method
used here is even simpler because no further fabrication pro-
cesses are required beyond Xurography.
The standard mercury light source in the microscope was
far too bright when focused on the sample, causing rapid
photobleaching. Neutral density ﬁlters were used to reduce
the excitation intensity and better match the ﬂuorescence
emission to the photomultiplier detector used. Alternative
light sources, such as high intensity LEDs to ﬂood illuminate
a small area without precise focusing are interesting options.
Furthermore, a charge-coupled-device (CCD) camera could
image a DNA melting array microchip, thereby creating a
higher throughput system. CCDs, although not as sensitive
as PMTs, should provide sufﬁcient S/N for nanoliter volume
melting of ampliﬁed DNA.
Conclusion
Solution-phase DNA melting analysis for mutation scanning
and genotyping can be performed in 10 nl reaction cham-
bers within a microchip. The 1000-fold reduction in sample
volume from 10 μl in state-of-the art commercial systems to
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Table 1 Signal-to-noise (S/N) and melting temperatures (Tms) of seven genotypes at three loci on the HR-1 (10 μl) and microchip (10 nl)
instruments
S/N Tm (◦C)
HR-1 Microchipa HR-1 Microchipb Tmc
ATM exon 17
Homozygous wild-type 2450 69 79.7 78.8 ± 0.7 0.9
Heterozygous mutant 2800 63 79.5 78.1 ± 0.8 1.4
CFTR exon 10
Homozygous wild-type 5000 168 82.4 80.7 ± 0.5 1.7
Heterozygous mutant 5350 135 82.4 79.9 ± 0.3 2.5
HFE C282Y
Homozygous wild-type 2680 76 79.6 79.4 ± 0.6 0.2
Heterozygous mutant 2290 60 78.4 77.8 ± 0.7 0.6
Homozygous mutant 2560 111 77.9 77.5 ± 0.5 0.4
aMicrochip S/N values are averaged over 3 unique melt curves for each genotype of ATM exon 17 and HFE C282Y. CFTR exon 10 represents
averaged values over ten unique melt curves for each genotype.
bMicrochip Tm reports the average value over three melts for ATM exon 17 and HFE C282Y targets and an average value over ten melts for CFTR
exon 10 with the standard deviation.
cValues represent the difference between the HR-1 Tm and the averaged Microchip Tm.
Fig. 7 Negative derivative plots for the microchip (A: 10 nl) and the
HR-1 (B: 10 μl) using the HFE C282Y target. Homozygous wild-
type template (red line); heterozygous mutant template (black line);
homozygous mutant template (blue dashed line)
10 nl on the microchip does result in a lower S/N, but is en-
tirely adequate for detecting and genotyping SNPs. Mutation
scanning was performed in 84 and 201-bp PCR products,
and complete SNP genotyping by melting a 40-bp target.
The characteristic features of the melting curves necessary
for scanning and genotyping are produced by both the nl mi-
crochip and the μl commercial instrument. The next logical
step is to integrate PCR with melting analysis on the mi-
crochip, potentially in an array format. Such a system would
be relatively easy to fabricate and could provide a rapid, inex-
pensive, high-throughput mutation scanning and genotyping
solution that requires no separations, processing, or labeled
probes.
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 This chapter makes S/N comparison between a commercial instrument and a 
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S/N for the microchip is only reduced by 1.5 orders of magnitude. It is clarified that this 
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microchip actually requires 1 μL to load. Within the commercial instrument the entire 10 









COMPARISON OF GLASS ETCHING TO XUROGRAPHY PROTOTYPING OF  
 
MICROFLUIDIC CHANNELS FOR DNA MELTING ANALYSIS 
 
 
This chapter has been reprinted with permission from IOP Publishing. The 
manuscript is published in Journal of Micromechanics and Microengineering, DOI 
10.1088/0960-1317/17/12/003. Authors are Jenny Greer, Scott O. Sundberg, Carl T. 













IOP PUBLISHING JOURNAL OF MICROMECHANICS AND MICROENGINEERING
J. Micromech. Microeng. 17 (2007) 2407–2413 doi:10.1088/0960-1317/17/12/003
Comparison of glass etching to
xurography prototyping of microﬂuidic
channels for DNA melting analysis
Jenny Greer1, Scott O Sundberg2, Carl T Wittwer3 and
Bruce K Gale1
1 Department of Mechanical Engineering, University of Utah, UT, USA
2 Department of Bioengineering, University of Utah, UT, USA
3 Department of Pathology, University of Utah, UT, USA
Received 31 May 2007, in ﬁnal form 27 September 2007
Published 25 October 2007
Online at stacks.iop.org/JMM/17/2407
Abstract
Two microchannel manufacturing methods—xurography of double-sided
tape and glass etching (lithography and wet etching)—were compared using
DNA melting analysis. A heterozygous mutation (3 base-pair deletion) was
distinguished from wild type (normal) DNA in 10 nL (xurography and glass
etching) and 1 nL (xurography) volumes. The results of the 10 nL and 1 nL
melting curves were compared to results using commercial high-resolution
instrumentation with 10 μL volumes. These 1000-fold and 10 000-fold
volume reductions reduced the signal-to-noise ratio (SNR) only 29-fold and
40-fold for xurography (10 nL and 1 nL, respectively,) and 39-fold for 10 nL
glass etched microchannels, still providing adequate discrimination for
mutation detection. The reduced SNR of the glass etched microchannels
compared to the tape microchannels was due to the in-house bonding
process which gave poor optical quality on the surface of the microchip.
Xurography of double-sided tape reduces the cost by 20 fold and is four
times faster to manufacture than glass etching. Microchips created using the
rapid prototyping technique of xurography are a reasonable prototyping
alternative to channels created using traditional glass etching for DNA
mutation detection.
(Some ﬁgures in this article are in colour only in the electronic version)
Introduction
Microﬂuidic technology for use in medical diagnostics,
forensics, microbial detection and other bio-analysis has
generated enormous interest in recent years (Verpoorte 2002).
An important analytical tool is the polymerase chain reaction
(PCR) (Sailki et al 1985), which can amplify a small region of
DNA over 106 fold in 10–15 min (Wittwer et al 1990). As a
complement to PCR, DNA melting analysis was introduced
in 1997 as a method of product identiﬁcation (Ririe et al
1997) though DNA melting, or denaturation, was used to
analyze the GC content of DNA as early as 1968 (Mandel
and Marmur 1968). In DNA melting analysis, a ﬂuorescent
dye is present which only ﬂuoresces when the DNA is in
double helix form. DNA melting occurs as the DNA sample
is heated, causing the double helix to separate into two
strands. Mutations are detected by analyzing themelting curve
(Wittwer et al 2003). Speciﬁc mutations manifest themselves
as a shift in temperature, a change in shape or a combination
of these (Gundry et al 2003). Current research is focused on
miniaturizing these processes to allow for high throughput at
a reduced cost while maintaining sufﬁcient SNR.
The traditional method for creating microﬂuidic PCR
devices is photolithography (Simpson et al 1998) with wet
etching (Iliescu and Tay 2005) using glass substrates. This
method requires a clean room to fabricate the channels, and
can be quite costly and time consuming. In recent years, rapid
prototyping technology for microﬂuidic devices has greatly
improved. Rapid prototyping is advantageous because designs
can be created quickly and at a reduced cost compared to
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Figure 1. DNA analysis wells: (A) 10 nL well in tape with 25 μm depth, (B) 1 nL well in tape with 25 μm depth and (C) 10 nL well in glass
with 22 μm depth.
traditional methods. This allows for more designs to be tested
in a given period of time, increasing the effectiveness of the
design phase. Some of the rapid prototyping technologies
include soft lithography techniques (Xia andWhitesides 1998)
with poly(dimethylsiloxane) PDMS (Shin et al 2003, Duffy
et al 1999, Kaigala et al 2007), laser micromachining (Yao
et al 2005, An et al 2006), micropowder blasting (Yagyu et al
2005) and micromachining (Schabmueller et al 2000, Neuzil
et al 2006) with glass or polymer substrates.
Recently, xurography (Bartholomeusz et al 2005) was
shown to be an effective method for developing microﬂuidic
channels. Xurography is the process of using a knife plotter
to cut various microﬂuidic designs out of assorted polymer
sheets. The unwanted portions of the polymers are removed
and the remaining polymer is placed on a substrate for
use. Xurography is an attractive alternative to other rapid
prototyping techniques due to its fast fabrication time, lack
of dependence on clean room facilities, and low equipment
and material cost. Using polymers with adhesives on both
sides allows for rapid bonding and sealing. Another appealing
characteristic of xurography is its dimensional accuracy of
10 μm with feature variability down to 2 μm. In a
recent example, the xurography process was used to create a
microﬂuidic channel and analysis well out of a biocompatible
tape, which was then used to perform DNA melting analysis
(Sundberg et al 2007). In the current work, xurography is
compared to glass microchip fabrication.
Materials and methods
Microﬂuidic chip fabrication
Xurography was used to manufacture the tape-bonded
microchannels. A knife plotter (Graphtec, Irvine, CA) cut the
geometric designs, created using Adobe IllustratorR© (Adobe,
San Jose, CA), out of 25 μm thick double coated tape (9019,
3M, St Paul, MN). A rhomboidal shapewas chosen for thewell
design to reduce the amount of bubbles in the well compared
to a circular shaped well. The rhomboidal well for 10 nL,
as seen in ﬁgure 1(A), expands the channel width of 300 μm
to a maximal width of 570 μm for 400 μm over its 800 μm
length. The 1 nL rhomboidal well, as seen in ﬁgure 1(B),
expands the channel width of 100 μm to a maximal width of
200 μm for 200 μm over its 400 μm length. Circular wells
of 2 mm diameter are placed 25 mm from center on either
side of the analysis wells for inlet and outlet ports. The tape
is sandwiched between two 25 mm × 75 mm glass slides
(12–550A, Fisher Scientiﬁc, NH). One of the glass slides has
two 2 mm holes drilled through the glass slide using a Dremel
tool with a diamond drill bit. The holes drilled through the
glass correspond to the inlet and outlet ports in the tape. To
insure a good bond between the glass and tape, themicroﬂuidic
chip is clamped with four spring-loaded clips before being
placed in a 65 ◦C oven for 45 min.
Photolithography and wet etching were used to
manufacture the glass-bonded microﬂuidic chips. A 25 mm ×
75 mm soda lime glass microscope slide was pre-cleaned with
a piranha etch (3 H2SO4: 1 H2O2) for 10 min. The etch
mask was formed by sputtering (Denton Discovery 18, Denton
Vacuum, Moorestown, NJ) a 900 nm layer of chromium
onto the glass slide followed by a 2 μm layer of photoresist
(1813, Shipley, Marlborough, MA) which was patterned using
standard photolithographic procedures. The glass slide was
then baked at 120 ◦C for 60 min and DuPont Kapton tape
(5419, 3M) used to mask the uncoated side of the glass
slide. Exposed metal was removed by dipping the slide into
a chromium etch bath (1 HF: 3HNO3: 10 H2O) for 17 min
at room temperature. The remaining photoresist and
chromium were stripped off by dipping the glass slide into
acetone before placing it in a chromium etch bath for 5 min
at room temperature. The resulting microﬂuidic channel was
150 μm in width and 25 μm deep with a circular analysis well
of 670 μm diameter, as seen in ﬁgure 1(C). At each end of the
50 mm channel two circular wells were pattered as guides for
the inlet and outlet ports, and were later drilled through using
a Dremel tool with a diamond drill bit. The etched glass slide,
along with a new glass slide, was put into piranha etch for
cleaning. The two glass slides were fused together by baking
them at 620 ◦C for 4 h under 58 Pa of pressure. See ﬁgure 2 for
a comparison of this technique with xurography as described
above.
Loading ﬂuid into the analysis well is the same for the
tape- and glass-bonded channels. The sample is loaded into the
inlet port and drawn through the channel and well by vacuum
pressure created with the use of a syringe at the outlet port. A
NanoPortTM assembly (Upchurch Scientiﬁc, Oak harbor, WA)
is attached to the glass over the outlet port and is connected
to the syringe with a luer ﬁtting. Figure 3 shows a picture of
microﬂuidic chip sample loading.
Sample preparation
PCR was performed in a LightCycler R© (Roche Applied
Science, Indianapolis, IN) having a 20 ◦C s−1 transition rate.
The initial denaturation occurred at 95 ◦C with a 5 s hold time,
followed by 33 temperature cycles of 95 ◦C with no hold time,
54 ◦C with no hold time and 72 ◦C with a 4 s hold time.
Each 10 μL mixture of CFTR exon 10 consisted of
200 μM deoxynucleotide triphosphate (dNTP), 0.4 U
2408
37
Comparison of glass etching to xurography prototyping of microﬂuidic channels for DNA melting analysis
Figure 2. Direct comparison of the process used to create microﬂuidic DNA melting analysis chips using xurography with double-sided
tape and the glass etching method (lithography and wet etching).
Figure 3. Loading the microﬂuidic channel, including the chip, the
NanoPortTM assembly and the syringe.
KlenTaq1 polymerase (AB Peptides, St Louis, MO), 88 ng
TaqStart antibody (ClonTech, Mountain View, CA), 2 mM
MgCl2, 1X LCGreen Plus (Idaho Technology, Salt Lake City,
UT) ﬂuorescent dye, 0.5 μM of each primer in 50 mM Tris
(pH 8.3), 500 ng μL−1 bovine serum albumin (BSA) and
50 ng human genomic DNA as the template. The PuregeneTM
GenomicDNAPuriﬁcationKit (Gentra Systems,Minneapolis,
MN) was used to isolate and purify the genomic DNA using
3 mL of whole blood. The DNA concentration was then
determined by absorbance at 260 nm (A260), assuming that
an A260 of 1.0 is 50 ng μL−1. The purity, according to
the A260/A280 absorption ratio, for all DNA templates was
a minimum of 1.8.
The CFTR exon 10 PCR product (Genbank Acc.#
M55115) was 201 base pairs in length with the 3 base pair
deletion F508del (Du et al 2005). Primers used to amplify the
segment were 5’-ACTTCTAATGGTGATTATGGG-3’ and 5’-
ACATAGTTTCTTACCTCTTC-3’.
Microchannel preparation
Before the sample is loaded into the tape-bonded
microchannels, the channel is coated with 2.5 mg mL−1
BSA by ﬁlling the channel with 2.5 mg mL−1 BSA at room
temperature for approximately 30 s. The channel is then
placed in a vacuum with a pressure of 12 psi for 1 h to
remove excess gas trapped by the adhesive. This process
reduces the amount of PCR product (amplicon) that sticks to
the channel walls and reduces bubble formation in the channel.
Higher concentrations of BSA reduced the SNR, as BSA has
some ﬂuorescence, while lower concentrations allowed more
amplicon to stick to the channel walls. Different microchips
were used for each genotype.
The glass-bonded microchannels were ﬁlled with
0.25 mg mL−1 BSA at room temperature for approximately
30 s before the samplewas loaded into the channel to reduce the
amount of amplicon that sticks to the channel walls. This BSA
concentration was optimal with glass for maintaining adequate
SNR while reducing the amount of amplicon sticking to the
channel walls. Between sample runs, the channel was cleaned
with DNA AwayTM (Molecular BioProducts, San Diego, CA),
and ﬂushed three times with DI water before ﬁlling with
0.25 mg mL−1 BSA.
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Figure 4. Diagram of the modiﬁed inverted microscope optics.
Fluorescence detection
A modiﬁed inverted microscope was used for ﬂuorescence
detection of the analysis chamber (ﬁgure 4). Excitation was
achieved by limiting the light intensity of a mercury arc lamp
(HBO50W,Carl Zeiss, Thornwood, NY) by passing it through
a series of neutral density ﬁlters (Edmund Optics, Barrington,
NJ), whose values are given in table 1 for each microﬂuidic
channel. The excitation light passed through a band pass
ﬁlter (426–446 nm, Chroma Technology Corp., Rockingham,
VT) before being reﬂected at a 45◦ incidence angle by a
dichroic beam splitter (455 nm long-pass, Chroma Technology
Corp.). The light was then focused onto the sample in the
analysis chamber by a 20× objective (Ph2 Achrostigmat,
NA = 0.45, Carl Zeiss) for the 10 nL analysis chambers or
a 32× objective (Ph1 Achrostigmat, NA = 0.40, Carl Zeiss)
for the 1 nL analysis chamber. When using this conﬁguration,
the excitation volume equals the analysis chamber volume.
The emitted light was then collected by the same objective
lens, directed back through the dichroic beam splitter and an
emission bandpass ﬁlter (460–500 nm, Chroma Technology
Corp.) A lenswith focal length 12.6mmanddiameter 25.4mm
(AT-SHL-9, CVI Spectral Products) then focused the light
into the end of a ﬁber optic cable (400 μm diameter UV/VIS
range, CVI Spectral Products, Putnam, CT). A photomultiplier
tube (PMT) module (714 Photomultiplier Detection System,
Photon Technology International, Birmingham, NJ) with a
R1527 PMT (Hamamatsu, Bridgewater, NJ) was connected
to the ﬁber optic cable. A data acquisition (DAQ) card
(PCI-MIO-16XE-10, National Instruments, Austin, TX)
collected the analog output of the PMT module before being
analyzed on a personal computer using LabView 7.1 (National
Instruments). Figure 5 shows a diagram (A) and a photograph
(B) of the custom system.
Temperature control
To heat the microﬂuidic chips uniformly, two 6.4 mm
thick aluminum blocks were stacked to create a 13 mm
(A)
(B)
Figure 5. (A) Diagram of the modiﬁed inverted microscope.
(B) Photograph of the system with (1) DAQ cards, (2) a
photomultiplier assembly, (3) a light source, (4) excitation and
emission ﬁlters and objective lens, (5) a thermocouple assembly and
(6) a microﬂuidic chip with a thermocouple, a Peltier heater and a
heat sink.
Table 1. Neutral density ﬁlter values.
Normal Mutation
10 nL tape 0.6 0.6
10 nL glass 0.9 1.5
1 nL tape 0.6 0.4
conduction plate. This plate was attached to a 20 × 40 ×
3.2 mm Peltier heater (HT4-6-21×43, Melcor, Trenton,
NJ) using a zinc oxide/silicone (TG-001, Melcor) heat
compound. The aluminum block was placed directly on the
glass microchannels over the interrogation well. A metal ﬁn
measuring 53× 53× 25mmattached to a small fan (50× 50×
10 mm, Commitment to Keep, Inc., Addison, TX) acted as a
heat sink and was placed on top of the heater. The Peltier was
connected to a power supply (Zero-Up, Lambda Instruments,
Neptune, NJ) that was controlled through a shielded connector
block (BNC-2110, National Instruments) by an analog output
from a PCI-6014 DAQ card (National Instruments). A heating
rate of 0.1 ◦C s−1 over a range of 70–88 ◦C was achieved
by increasing a 4.7 V power supply input by 6.4 mV s−1. A
J-type thermocouple (TT-J-40-50, Omega, Stamford, CT) was
placed in a 2 mm diameter hole, drilled 1–2 mm way from the
interrogation well, ﬁlled with heat compound. Kapton tape
secured the thermocouple to the glass slide. Photographic
tape (235, 3M) was placed over the Kapton tape to eliminate
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(A) (B)
(C) (D)
Figure 6. Melting curves for normal DNA (red) and heterozygous DNA (black) found using: (A) commercial HR-1TM, (B) 10 nL tape,
(C) 10 nL glass and (D) 1 nL tape.
excess ﬂuorescence. The thermocouple signal was ampliﬁed
and linearized (AD594, Analog Devices, Norwood, MA)
before being sent to a PCI-MIO-16XE-10 DAQ card through a
shielded I/Oconnector block (SCB-68, National Instruments).
Calibration of the temperature to within ±0.3 ◦C at 50 ◦C was
accomplished with a Fluke thermometer (54 II Thermometer,
Fluke, Everett, WA).
Melting curve acquisition and analysis
A high resolution reference melting curve was obtained after
ampliﬁcation by transferring the LightCyclerR© capillary to a
HR-1TM instrument (Idaho Technology) that was heated at
0.1 ◦C s−1. The sample was then spun into a microfuge tube.
Using amicropipette, 2μLof samplewas inserted into the inlet
port of the microchannel. The sample was then drawn through
the channel using vacuum pressure created by a syringe on
the outlet port. Plugs designed to ﬁt snugly over the inlet
and outlet ports, made of Paraﬁlm (PM-996, Pechiney Plastic
Packaging, Menasha, WI), were placed over the ports and held
ﬁrmly with Kapton tape. The analysis chamber was aligned
with the optics using the x- and y-axis stage of the inverted
microscope, while focus was achieved using the z-axis. Two
data points were acquired every second as the sample was
heated at a rate of 0.1 ◦C s−1.
Custom LabView (Gundry et al 2003, Wittwer et al
2003) software analyzed the data from the HR-1TM and
the microﬂuidic chip. The ﬂuorescence intensity data was
normalized by deﬁning a linear baseline before and after the
melting transition of each sample. Then, the curves were
superimposed by adjusting the temperature axis in order to
compare the melting curve shapes. Signal-to-noise ratios
(SNR)were calculated for each sample as described previously
(Herrmann et al 2006).
Results and discussion
Mutation detection using DNA melting in the 10 nL tape
bondedmicrochannels was comparable to the traditional glass-
bonded 10 nLmicrochannels in terms of the SNR, temperature
variation and shape distinction of melting curves. 10 nL is
about a 1000 fold reduction from current commercial systems
for DNA melting analysis. Figure 6 shows the melting curves
for PCR products ampliﬁed from normal DNA (red) and
heterozygous DNA (black). Heterozygous sequence variants
are identiﬁed by the altered shape in the melting curve, which
is a result of heteroduplexes (Gundry et al 2003, Wittwer et al
2003), or mismatched pairs in DNAduplexes. Panel (A) shows
melting curves from the commercial HR-1TM instrument using
a 10 μL sample. The HR-1TM instrument, the current
‘gold standard’ for high-resolution melting analysis, records
200 data points for every 1 ◦C and has a standard deviation
of less than 0.02 ◦C (Herrmann et al 2006). Panels (B) and
(C) show melting curves for a 10 nL sample using the tape-
bonded channels and the glass-bonded channels, respectively.
The results of six melting curves for each fabrication method
are in agreement with the standard HR-1TM instrument, and
are comparable. Panel (D) shows the melting curves for 1 nL
samples using xurography to create tape-bonded channels.
Table 2 lists the SNR and the melting curve temperature
(Tm) for each of the melting analysis chambers. The SNR
of the 10 nL melting curves for both the glass-bonded and
tape-bonded microchannels is 1.5 orders of magnitude smaller
than the commercial HR-1TM system, while the volume was
reduced by 3 orders of magnitude. The SNR of the 10 nL tape
bonded microchannels was comparable to that of the glass-
bonded microchannels. The SNR for the 1 nL tape bonded
microchannel is approximately 30% less than that of the
10 nL tape bonded channels. The Tm standard deviations
were between 0.1–0.8 ◦C.
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Table 2. SNRs and average Tms for the melting curves.
HR-1 10 nL Tape 10 nL Glass 1 nL Tape
Normal Mutation Normal Mutation Normal Mutation Normal Mutation
SNRa 5470 5040 188 174 131 136 126 135
SDb ±15 ±10 ±12 ±6 ±17 ±18
Tm (◦C)c 82.2 82.2 82.4 81.1 78.3 77.0 81.5 81.4
SDb ±0.1 ±0.3 ±0.3 ±0.8 ±0.1 ±0.5
a SNRs are an average of six melting curves.
b SD (standard deviation for six melting curves).
c Tms are an average of six melting curves for each genotype before temperature shifting.
The difference between the SNR from the tape and
glass-bonded microchannels, with tape being slightly higher,
suggests that the capabilities of the two techniques are similar
and xurography can be used in place of glass etching. The
lower SNR than that seen in the HR-1TM are likely caused
by more than just the reduction in volume. For the glass-
and tape-bonded microchannels, the signal is reduced if light
is scattered from small imperfections along the edges of the
analysis chambers. These imperfections can be created during
manufacturing. For photolithography, residual stresses in
the chrome layer may create an uneven etch, while small
vibrations in the cutting blade used in xurography may create
an uneven cut. For the glass-bonded microchannels, some
loss in SNR can be explained by the poor optical quality of
the glass chips. Metal blocks are used as weights to provide
pressure for bonding the glass slides together during the sealing
process. Although the metal blocks are reasonably smooth,
small imperfections may be transferred onto the surface of the
glass channels. These small imperfections on the glass surface
may disrupt the optical path, thus reducing the amount of light
and decreasing the SNR. The decreased SNR caused by the
metal blocks could be overcome with better, more expensive
and time-consuming techniques and equipment, such as a
mask bonder/aligner (Grosse et al 2001) or anodic bonding
(Berthold et al 2000). In the tape-bonded channels, the SNR
could be increased by using a different type of adhesive
or other bonding material. The double-sided tape used for
this process also has some background ﬂuorescence which
decreases the SNR. The temperature variations are accounted
for by thermocouple placement relative to the analysis well
(1–2 mm variation). However, these temperature variations
do not matter for heterozygous variant detection as shape is
used to distinguish these variants from normalDNA (Sundberg
et al 2007).
Despite these imperfections, the SNRs for the tape and
glass-bonded channels are adequate for mutation scanning and
detection, as seen in ﬁgure 6. Tape-bonded microchannels
are an effective alternative to the traditional glass-bonded
microchannels. One of the major advantages of the
tape-bonded microchannels is the cost. The traditional
glass microﬂuidic chips have a material and equipment
cost of $400.00 for six microchips, while the tape-bonded
microchannels cost less than $2.00 for six microchips. A
second advantage of the tape-bonded microchips is the time
in which the microchannels can be made. To make six
tape-bonded microchannels, it takes approximately 2 h to
fabricate and assemble, with an additional 45 min of bake
time for bonding purposes. In contrast, the glass-bonded






















































Includes 1 hr of design time and mask generation time
Clean Room usage price is $45/hr
Labor is $20/hr
Figure 7. Time and cost comparison of glass (dark blue) and tape
(light blue) microchannel fabrication for melting analysis.
microchannels take approximately 8 h to fabricate, with an
additional 4.5 h of bake time to bond the channels. Including
the price of labor with the total manufacturing costs, the price
would be over $750 for six glass microchips, while the tape
channels are $41 for six, assuming the labor is $20 dollars
an hour. To have glass-bonded microchannels fabricated
professionally, it is approximately $6000 for six chips.
Figure 7 summarizes the time and cost of each method.
Another advantage of tape-bonded microchannels as a
prototyping tool is the ability to change designs quickly and
inexpensively. One major disadvantage of the glass-bonded
microchannels is that each time a new microﬂuidic design
is needed, a new mask must be made. To make a mask
for an original design, it costs a minimum of $200 (usually
much more) and takes between 1 and 8 h, depending on the
complexity of the design. This does not include the time
required to generate the design using a CAD program. In
contrast, the tape-bonded microchannels are not hampered
by the necessity of having to generate a costly mask. To
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create a newdesign in the tape-bondedmicrochannels, a design
generated from a CAD program can be cut immediately into
the tape which is used to make the microﬂuidic channel.
One disadvantage of the tape-bonded microchannels is
their life span. Although tape-bonded microchannels can
be used more than once, the tape microchannels gradually
deteriorate with repeated use and bubbles eventually enter the
channel. In contrast, the glass-bonded microchannels can be
used many times without apparent deterioration, as long as the
channels are cleaned between runs. A second shortcoming of
tape-bonded microchannels is the surface quality. Roughness
along the channel walls is a result of gaps in the adhesives
and vibrations in the cutting knife as it cuts the tape. A
ﬁnal disadvantage of the tape-bonded microchannels is that
they are prone to produce bubbles at temperatures above
85 ◦C. Air pockets which are present between the tape and
the glass bonding substrate may expand into the chamber at
higher temperatures.
Conclusion
Xurography using double-sided tape is an effective and
reliable prototyping alternative to traditional glass etched
microchannels. DNA melting analysis performed in the 10 nL
tape bonded microchannels was comparable to the 10 nL glass
bonded microchannels. The 10 nL and 1 nL volume channels
had a 1000-fold and 10 000-fold volume reduction from
commercial high resolution DNA melting instrumentation,
with only a 10-fold SNR reduction, and were adequate for
heterozygote mutation detection. Despite having a shorter
life span than the traditional glass-bonded microchannels, the
tape-bonded microchannels are signiﬁcantly less expensive
and faster to make, making them an effective prototyping tool
for DNA melting analysis.
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Abstract
Solution-phase, homogeneous DNA melting analysis was performed in 100 nl volumes on 
a custom microchip/instrument and compared to the gold-standard 10 l HR-1™ melting 
instrument for the VKORC1 C1173T, CYP2C9*2 and CYP2C9*3 targets, the genetic targets 
involved in determining warfarin dosing used in blood thinners.  Normal sample was 
distinguished from heterozygous and homozygous single-nucleotide polymorphisms (SNPs) 
simultaneously in an array melting platform using an automatic genotype calling melting 
analysis software. 
Introduction
Warfarin is one of the most widely used coumadin anticoagulants but has a wide 
interindividual dosage variation.  Variants in the VKORC1 and CYP2C9 genes and certain 
environmental conditions (i.e. age, bodyweight and drug interactions) account for about 50-
60% of the variation in warfarin dosage (Sconce et al. 2005 and Wadelius et al. 2007).  
Warfarin functions by interfering with vitamin K recycling in the liver.  VKORC1 encodes for the 
main protein in the vitamin K epoxide reductase complex.  Warfarin is metabolized by 
cytochrome P450 2C9 (CYP2C9).  Thus, CYP2C9 *2 and *3 alleles require lower warfarin 
doses and may have a greater risk of bleeding (Sanderson et al. 2005). 
DNA melting analysis as a complement to PCR was introduced in 1997 (Ririe et al. 1997). 
A dye is included in the PCR that fluoresces in the presence of double-stranded DNA, but not 
single-stranded DNA. After amplification, fluorescence is monitored as the double-stranded 
DNA product is slowly heated. When the double helix melts, fluorescence rapidly decreases. 
The negative first derivative of fluorescence with respect to temperature shows the melting 
temperature (Tm) as maxima. Recent advances in melting instrumentation (Herrmann et al. 
2006) and saturating DNA dyes (Wittwer et al. 2003) allow detection of single nucleotide 
polymorphisms (SNPs). If the change is heterozygous, DNA heteroduplexes alter the shape of 
the melting curve (Reed et al. 2004). If the change is homozygous, the absolute temperature of 
the melting transition shifts (Liew et al. 2004). DNA melting analysis, when compared to 
existing PCR analytical techniques, is advantageous because it is less complicated, faster 
(less than 20 minutes for PCR and analysis), and prevents contamination of the sample and 
environment due to its “closed-tube” format (Zhou et al. 2004). The specific dye used 
determines the capabilities of the method; LCGreen® Plus detects homozygous and 
heterozygous sequences well and does not inhibit PCR (Wittwer et al. 2003).
Analysis of the melting transition is often sufficient for genotyping. However, unlabeled 
probes combined with asymmetric PCR provide even greater specificity over a smaller region, 
which may be necessary for variant discrimination (Zhou et al. 2005) and is commonly 
believed to be essential for clinical assays.  A recent publication has demonstrated that DNA 
44
melting analysis is capable of being miniaturized, thus providing initial results for a microarray 
chip platform, reducing reagent costs (Sundberg et al. 2007).
Materials and Methods 
Microchip Fabrication 
Xurography (Bartholomeusz et al. 2005) was used to create a PDMS soft lithography mold, 
with analysis wells being 1.125 mm in diameter and 0.1 mm in height, creating a 100 nl 
volume.  PDMS was then molded and cured in an oven.  PDMS ports were cored and then 
bonded to glass slide substrates using corona discharge, Figure 1.   
Figure 1.  Photograph of the custom microchip showing three channels with three wells per 
channel.  Each well has a diameter of 1.125 mm and a depth of 0.1 mm.
Instrumentation
A Peltier heater (HT4-6-21x43, Melcor, Trenton, NJ) and J-type thermocouple were used 
for temperature control.  Detection used a CCD camera (iXon, Andor Technology, South 
Windsor, CT) cooled to -80 °C.  LEDs (440-460 nm, LXHL-BR02, LUXEON, Philips Lumileds 
Lighting Company, San Jose, CA) were filtered by an excitation bandpass filter (426-450 nm, 
Brightline Fluorescent Filters, Semrock, Rochester, New York).  Emitted light was collected by 
a lens (EFS 60mm f/2.8 Macro, Canon, Lake Success, New York) and passed through an 
emission bandpass filter (467-499 nm, Brightline Fluorescent Filters, Semrock) (Figure 2).  All 
hardware was controlled using LabView 8.0 (NI, Austin, TX).
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Figure 2.  A photograph of the prototype detection instrumentation is shown.  (1) CCD camera; 
(2) LED ring for fluorescence excitation; (3) heating platform using a Peltier heater; (4) 
thermocouple control; and (5) LED power supply. 
Sample Preparation 
10X asymmetric PCR with unlabeled oligonucleotide probes was performed on the DNA 
sample using a LightCycler® and then transferred to an HR-1™ instrument for a high-
resolution reference melting curve.  2 l of the amplified sample was pipetted into the 
microchip for nanoliter melting analysis.  All three genotypes were melted simultaneously and 
each genotype had three wells for repeat analysis. 
Software
The automatic calling software uses an agglomerative, unbiased hierarchical clustering of 
melting curves (Duda et al. 2001) to make the calls.  Given n curves, the two curves that are 
closest to each other are first determined.  The distance between a pair of curves is taken as 
the mean absolute value of the fluorescence differences between the curves over all 
temperature acquisitions.  The closest two curves are deleted and replaced by their mean, 
resulting in a new set of n-1 curves.  The next nearest pair is then replaced by the weighted 
mean of that pair.  At each step, the weight is the number of original curves that make up each 
branch being averaged.  This process is performed a total of n-1 times until the last pair of 
curves is merged, producing a dendrogram showing the most likely clusters at each level.  The 
process does not determine the number of clusters (i.e. the number of genotypes) represented 
by the n curves but does confirm appropriate clustering of samples at each dendrogram level.  
For these tests three clusters were chosen to represent each of the three genotypes. 
Results and Conclusion 
Figures 3, 4 and 5 show negative derivative melt plots of normal, heterozygous, and 
homozygous SNPs within a 190-bp fragment of VKORC1 C1173T, a 122 bp fragment of 
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CYP2C9*2 and 134 bp fragment of CYP2C9*3.  The 100 nl melts are in good agreement with 
the 10 l HR-1 melting curves and each of the genotypes were clearly distinguished in their 
first melt transition, the unlabeled probe melt region, using an automatic calling software (Idaho 
Technology) to distinguish the genotypes by setting the cluster number to three.  This new 
platform provides accurate SNP genotyping capability using a hundredth of the volume 
currently used with gold-standard instrumentation.  This technology with further development 
will lead to a more accurate warfarin dosing within the clinical setting. 
Figure 3.  VKORC1 C1173T negative derivative plots of 100 nl melts (left) and 10 l melts 
(right). Normal DNA (red); heterozygous mutation (black); and homozygous mutation (blue). 
Figure 4.  CYP2C9*2 negative derivative plots of 100 nl melts (left) and 10 l melts (right). 
Normal DNA (red) and heterozygous mutation (black). 
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Figure 5.  CYP2C9*3 negative derivative plots of 100 nl melts (left) and 10 l melts (right). 
Normal DNA (red); heterozygous mutation (black); and homozygous mutation (blue). 
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An inexpensive plastic disk disposable was designed for
digital polymerase chain reaction (PCR) applications with
a microﬂuidic architecture that passively compartmental-
izes a sample into 1000 nanoliter-sized wells by centrifu-
gation. Well volumes of 33 nL were attained with a 16%
volume coefﬁcient of variation (CV). A rapid air thermocy-
cler with aggregate real-time ﬂuorescence detection was
used, achieving PCR cycle times of 33 s and 94% PCR
efﬁciency, with a melting curve to validate product speci-
ﬁcity. A CCD camera acquired a ﬂuorescent image of the
disk following PCR, and the well intensity frequency
distribution and Poisson distribution statistics were used
to count the positive wells on the disk to determine the
number of template molecules ampliﬁed. A 300 bp
plasmid DNA product was ampliﬁed within the disk and
analyzed in 50 min with 58-1000 wells containing
plasmid template. Target concentrations measured by the
spinning disk platform were 3 times less than that
predicted by absorbance measurements. The spinning
disk platform reduces disposable cost, instrument com-
plexity, and thermocycling time compared to other current
digital PCR platforms.
Digital polymerase chain reaction (PCR) is a highly sensitive
DNA and RNA quantiﬁcation technique that counts each template
individually. This technique provides greater precision over
quantitative real-time PCR (qPCR) because it is not sensitive to
PCR efﬁciency, transforming exponential, analog signals to linear,
digital signals.1 First published in 1999, limiting dilution was used
to detect a minor fraction of altered DNA by diluting to the point
of having 0.5 DNA templates per PCR in a microtiter plate format.2
Molecular beacon probes were analyzed following PCR to quantify
the wild type to rare mutation ratio, relying on binary positive/
negative calls.
More recently, the concept of digital PCR has been miniatur-
ized to nanoliter volumes using microﬂuidics to limit the amount
of DNA template in a PCR.3 Miniaturization of PCR volume has
beneﬁted digital PCR in three signiﬁcant ways. First, reagent
consumption is reduced 100 to 1000-fold from microtiter plate
formats, reducing testing costs dramatically. Second, the number
of parallel reactions has increased over 100-fold, thus increasing
power, sensitivity, and throughput. Third, testing is simpliﬁed by
reducing sample dilution steps, using volume as a limiting factor,
and eliminating several pipetting steps required with microtiter
plates. Miniaturization of digital PCR has been investigated down
to 65 pL reaction volumes.4
Applications of microﬂuidic digital PCR include detection of
rare mutations within an excess of normal DNA,5 multigene
analysis of bacteria,6 copy number variation,7 fetal DNA in
maternal plasma,8 and genetic allelic imbalance.9,10
The purpose of this work is to improve upon current microf-
luidic digital PCR platforms by reducing disposable costs, instru-
ment complexity, and time to result. Our design loads the sample
into nanoliter-sized compartments by centrifugation, eliminating
the need for valves and pumps and reducing microﬂuidic loading
time. The disk consists of three inexpensive plastic thin ﬁlm sheets
laminated together with an architecture that passively divides a
spun sample into a thousand compartments, reducing chip
disposable costs. PCR is performed on the rotating disk by rapid
thermal cycling in an air chamber, reducing thermocycling time.
After PCR, each compartment is interrogated for a positive/
negative signal by ﬂuorescence imaging.
In this work, we demonstrate microﬂuidic digital PCR within
a spinning disk platform in less than 35 min (including disk
loading, PCR thermocycling, and ﬂuorescent imaging). A single
disk provides 1000 nanoliter-sized reactions detected with the
dsDNA ﬂuorescent saturating dye LCGreen.11 No labeled probes
are required.
MATERIALS AND METHODS
Disk Design and Manufacturing. The disk design is based
on the use of centrifugal force to move ﬂuid along a spiral channel,
ﬁlling wells along the way. A loading reservoir located near the
center of the disk is connected to a spiral channel, 250 μm wide,
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that moves toward the outside of the disk. Along the channel are
square wells, facing radially outward along the spiral, which are
designed as ﬂuid traps. This design is fabricated from thin ﬁlm
plastics to create an inexpensive disposable, requiring only
centrifugation for ﬂuid control. The current design consists of 1000
wells each having dimensions of 500 μm × 500 μm × 125 μm. The
entire disk is 120 mm in diameter, the size of a CD, and is 375
μm thick. The channel layer disks were manufactured using the
process of xurography.12,13 Figure 1 illustrates the disk design
(see Supporting Information for more details).
Sample Preparation.We evaluated the feasibility of digital PCR
within the spinning disk using a previously developed DNA “Tool-
box”.14 Plasmid from the DNA Toolbox was provided by Lonza
(Rockland, ME). The PCRmixture contained plasmid DNA, ranging
from 6 × 106 to 6 × 100 copies/μL (determined by absorbance) as
the template. Preparation details of the plasmid DNA and PCR
mixture can be found in the Supporting Information.
Disk Loading. The sample was loaded by pipetting 40 μL of
PCR mix and 250 μL of mineral oil (M5904, Sigma-Aldrich
Corporation), dyed with Oil Red O (Matheson Coleman & Bell,
Gardena, CA), into the loading reservoir of the disk. Two
polycarbonate disks, 750 μm thick with an outer diameter of 75
mm, were then coupled to each side of the disk, using a two-
piece collar, to provide more rigidity to the disk during thermocy-
cling. The disk was then spun at 4000 rpm for 5 min to move the
ﬂuid from the middle to the outside of the disk, ﬁlling each of
the wells along the way and leaving the channel ﬁlled with the
mineral oil, as seen in Figure S1 in the Supporting Information.
The end of the spiral channel was then thermally sealed prior to
thermocycling to create a closed system. The collar was attached
to the servo motor shaft within the thermocycler using a set screw.
Thermocycling. A previously described rapid air thermocy-
cling instrument15 was modiﬁed to spin the disk at controllable
speeds, measure disk temperature during thermocycling, and
measure the average ﬂuorescence of disk wells, as seen in Figure
S2 (see Supporting Information for more details). Forty-ﬁve cycles
of 45 °C annealing for 0 s, 72 °C extension for 2 s, and 90 °C
denaturing for 0 s was achieved in under 25 min while spinning
the disk at 2500 rpm (33 s/cycle).
A ﬂuorimeter was mounted to the thermocycler with an
excitation spot size of 1 mm in diameter aimed 45 mm from the
center of the disk, providing an average real-time ﬂuorescence
reading over hundreds of wells due to the disk spinning during
ﬂuorescence acquisition (see Supporting Information for details).
The ﬂuorimeter optics scheme is shown in Figure S3. The real-
time ﬂuorescence data at PCR extension was normalized, multiply-
ing the extension ﬂuorescence value by the difference between
the annealing and denaturing ﬂuorescence values at each cycle.
The quantiﬁcation cycle (Cq) for each test was determined by
inputting these normalized ﬂuorescence values into LightCycler
Software vs 3 (Roche Diagnostics, Indianapolis, IN). The
melting temperature (Tm) of the ampliﬁed product was also
determined by LightCycler software, inputting the temperature
and ﬂuorescence data for the last thermocycle between 70 and
90 °C. The Tm is deﬁned as the maxima of the negative ﬁrst
derivative of ﬂuorescence.16 The ﬂuorescent signal is sufﬁcient
to obtain melting curves even within nanoliter volumes.17
Disk Imaging and Analysis. The disk was ﬂuorescently
imaged following PCR for digital well analysis, with the imaging
setup seen in Figure S4 (see Supporting Information for more
details). ImageJ18 software was used to threshold, size exclude,
and then create histograms of well intensity for each disk image.
The threshold and minimum pixel number was operator deﬁned.
Histogram frequency distributions were then used to determine
the number of positive and negative wells for each test.
Measuring Well Volume Variation. PCR amplicon with
dsDNA ﬂuorescent dye and mineral oil were spun into the disk
to determine well volume variation. A ﬂuorescent image of the
disk was taken. The number of pixels of each well along with the
mean and standard deviation of well ﬂuorescence was obtained
using custom LabView software. The pixels were used to calculate
the surface area of ﬂuid within each well. This surface area was
then multiplied by the depth of the well, which is the thickness
of the middle layer of plastic, to determine well volume. A
nonﬂuorescent imaging method was also used to determine well
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Figure 1. Spinning disk design, with dimensions given in millimeters,
shown to scale. The disk consists of a loading reservoir, spiral micro-
channel with 1000 wells facing radially outward along the channel, and
an overﬂow channel at the edge of the disk. The PCR mixture is pipetted
into the loading reservoir at location 1, and mineral oil is pipetted into
the loading reservoir at location 2. The Teﬂon inserts for the loading
reservoir are also shown (3). A pin-sized hole is located at the end of
the overﬂow channel (4), and once the disk is loaded, this same location
is thermally sealed, creating a closed system for PCR.
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manufacturing variation. Well dimensions were determined by
measuring the edges of 5% of the wells to calculate the surface
area, using pixels to determine edge lengths, and then multiplying
the surface area by well depth for manufactured well volume
variation.
RESULTS AND DISCUSSION
The spinning disk platform performed digital PCR with rapid
PCR thermocycling using only a dsDNA ﬂuorescent saturating
dye, providing quantiﬁcation results within 50 min. Thermocycle
times (33 s cycles) were much faster than some reported platforms
(∼120 s cycles3 and 55 s cycles4). The disk disposable was
inexpensive and easy to load, requiring less than 5 min. Fluores-
cent imaging of the disk required an additional 5 min. Image
analysis required 15 min for positive well quantiﬁcation but could
be streamlined in future software. Microﬂuidics allows digital PCR
to use much less reagent than microtiter plate systems, and the
absence of labeled probes further reduced costs by simply using
a dsDNA ﬂuorescent saturating dye.
Well Volume Variation. PCR amplicon with dsDNA dye and
mineral oil were spun into the disk to determine well volume
variation. The wells had a mean volume of 33 nL with a standard
deviation of ±5.2 nL or a 16% volume CV, across all 1000 wells. It
was further found that the manufacturing method alone causes a
10% volume CV due to variation in well cutting from the cutting
plotter based on cut well dimensions.
Dilution Series. A dilution series was performed using the
spinning disk platform to determine PCR efﬁciency and to identify
the concentrations required for optimal digital PCR results. The
dilution series ranged from 6 × 106 to 6 × 100 plasmid copies/
μL, or about 200 000 to 0.2 plasmid copies/well. An example
of the unprocessed real-time data is shown in Figure 2 for the
highest plasmid concentration of 6 × 106 plasmid copies/μL.
Figure S5 in the Supporting Information shows the real-time
PCR curves for each dilution. Table 1 provides the Cqs, Tms, and
number of positive wells for each plasmid concentration run
in the spinning disk platform. A PCR efﬁciency of 94% was
calculated, using the 6 × 106 to 6 × 102 Cq data and excluding
the last two concentrations because they were in the “digital
range”, from the equation
PCR efficiency ) 10-1/slope - 1 (1)
where the slope is found when the logarithm of template
concentration is plotted on the x axis and Cq is plotted on the y
axis. The slope was -3.47 with a correlation coefﬁcient, R2
value, of 0.989 for the dilution series. Figure 3 shows ﬂuorescent
images of the disk for the four lowest concentrations in the dilution
series. A histogram for the concentration of 6 × 101 plasmid
copies/μL is also shown in Figure 3 to illustrate the frequency
distributions that were used to determine the number of positive
wells within each disk. The PCR product Tms had a mean
temperature of 84.4 °C and a standard deviation of 0.7 °C. The
Tm helps validate PCR product speciﬁcity.
The digital PCR concentrations, 6 × 101 and 6 × 100 plasmid
copies/μL, had 518 and 58 positive wells, respectively. Because
the plasmid is homogeneously mixed within the PCR, a Poisson
distribution is assumed to statistically determine the number
of plasmid copies present for each disk. As the number of
positive wells increases, the chance of having more than one
copy of DNA in a given positive well also increases. The
Poisson distribution follows the equation
f(x) ) (λx) × (e-λ)/(x!) (2)
Figure 2. Real-time plots are shown of temperature vs time (top),
ﬂuorescence vs time (middle), and ﬂuorescence vs temperature
(bottom) at a concentration of 6 × 106 plasmid copies/μL. The top
plot illustrates that 45 thermocycles required less than 25 min; the
middle plot shows the exponential increase in ﬂuorescence with a
Cq of 16, and the bottom plot provides the Tm of the ampliﬁed product,
seen at 84.6 °C.
Table 1. Quantiﬁcation Cycle (Cq), Melting
Temperature (Tm), and Number of Positive Wells for
Template Dilution on the Spinning PCR Disk
conc. [copies/μL] Cq [cycle no.] Tm [°C] positive wells
6 × 106 16 84.6 997
6 × 105 19.57 85.3 992
6 × 104 24.05 84.6 974
6 × 103 27.13 84.5 995
6 × 102 29.57 83.1 939
6 × 101 32.02 84.1 518
6 × 100 32.28 a 58
a Signal was too low to detect the melting transition at this
concentration.
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where λ is the mean number of template copies and x is the
number of templates of interest present for a given well. If 48.2%
of the wells are empty, as is the case with the 6 × 101 plasmid
copies/μL disk, then the expected number of copies per well
is -ln 0.482 or 0.730 (which is the λ value solved when f(0) )
0.482 and x ) 0). Therefore, although 518 positive wells are
present, there are ∼730 plasmid copies that have actually been
ampliﬁed. A similar calculation is made for the 6 × 100 plasmid
copies/μL disk in which the expected number of copies per
well is 0.060; in other words, ∼60 plasmid copies were ampliﬁed
although 58 positive wells were counted.
A discrepancy exists between the absorbance measurements
of the plasmid and the digital results found in the two lowest
concentrations. At 6 × 101 plasmid copies/μL, there should be
2 copies/well although only 0.730 copies per well was mea-
sured, and at 6 × 100 plasmid copies/μL, there should be 0.2
plasmid copies/well although only 0.060 plasmid copies/well
was measured. This means that the spinning disk platform
differs from absorbance measurements by about a factor of 3.
The plasmid purity is unknown and may account for some of
the discrepancy. There may also be a portion of the plasmid
not cleaved or linearized that delays PCR ampliﬁcation. Another
possibility is that some of the plasmid may adsorb to the plastic
as it moves through the loading reservoir and spiral micro-
channel. The addition of PVP to the PCR mix diminishes these
effects greatly but may not entirely resolve the issue. This is
apparent in the three lowest concentrations where the ﬁrst
several wells do not ﬂuoresce, possibly caused by plasmid
adsorbing to the plastic in the frontrunner ﬂuid and then ﬁlling
those ﬁrst wells without template.
Figure 3. (Top) Fluorescent images are presented for 6 × 103 plasmid copies/μL (A), 6 × 102 plasmid copies/μL (B), 6 × 101 plasmid copies/
μL (C), and 6 × 100 plasmid copies/μL (D). A lower right section of each disk image is enlarged. Digital PCR is achieved with dilutions C and
D, where image C has 518 and image D has 58 out of 1000 wells ﬂuorescing. (Bottom) An example of the histogram data used to determine
the number of positive wells is shown for the 6 × 101 plasmid copies/μL concentration.
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Not all wells ﬂuoresced with the positive controls. Some of
this stems from the cutting plotter which occasionally creates
undesirable ridges next to a well, causing irregular ﬂuid ﬂow and
allowing mineral oil to ﬁll the well rather than the PCR mix. The
other issue is that the disk manufacturing did not take place in a
clean room, and therefore, an occasional dust particle was present
in a well, disrupting adequate PCR ampliﬁcation.
CONCLUSION
Plasmid DNA was efﬁciently PCR ampliﬁed within the spinning
disk platform and analyzed in 50 min with 58-1000 wells
containing template. Subsequent work will focus on improving
the plastic disk manufacturing, eliminating DNA adsorption to the
disk, reducing analysis time, designing a rapid air cycler ﬁtted to
the disk for faster thermocycling, and investigating new digital
PCR applications. A ﬂuorescent scanner for the disk is also
envisioned to replace disk imaging following PCR to provide
higher “on/off” ﬂuorescence resolution and further reduce
instrumentation cost.
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Supporting Information 
Spinning Disk Platform for Microfluidic Digital PCR 
Scott O. Sundberg*, Carl T. Wittwer, Chao Gao, and Bruce K. Gale 
MATERIALS AND METHODS (SUPPORTING INFORMATION) 
Disk Design and Manufacturing
When selecting disk material and manufacturing techniques the following were considered: low auto-
fluorescence levels at 425-550 nm excitation, minimal PCR inhibition, capable of withstanding 
thermocycling temperatures, ease of channel fabrication, low cost, and an easy bonding method.  The 
solution found was to use a cutting plotter to pattern a layer of glycol-modified polyethylene 
teraphthalate (PETG) and laminate that layer between two separate PETG layers. 
The channel layer disks were manufactured using the process of xurography. This process includes 
designing the microchannel pattern with SolidWorks® (Concord, MA), importing the design into 
Adobe Illustrator® (Adobe, San Jose, CA) and exporting to a cutting plotter (CE5000-60, Graphtec, 
Santa Ana, CA). A PETG thin film sheet, 125 m thick, (Sabic Polymershapes, Fresno, CA) was cut 
with the spiral channel and 1000 wells. This patterned sheet was then thermally bonded between two 
other PETG thin film sheets of the same thickness by laminating the plastics together at 130°C using an 
EL-12 laminator (Ibico, Skokie, IL).  Three 500 m thick Teflon strips (Scientific Commodities 
Incorporated, Lake Havasu City, AZ) were inserted into the loading reservoir to allow more loading 
volume and a pin-sized hole was created at the very end of the channel to allow air to escape while 
loading the fluid.
Sample Preparation
Plasmid from a DNA Toolbox was used as the template. Briefly, a 1000 bp region with an 
approximate GC content of 40% was identified in M13 and this construct was placed into pUC19 
plasmid. Forward primer 5’ GATATTTGAAGTCTTTCGGG 3’ and reverse primer 5’ 
1
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TAAGAGCAACACTATCATAA 3’ were used to amplify a 300 bp product. The concentration of 
initial plasmid stock was determined by absorbance at 260 nm (A260), assuming an A260 of 1.0 is 50 
mg/L. A 10X series dilution was performed with the plasmid DNA, ranging from 6 x 109 to 6 x 101
copies/L. Fifty L of each dilution was added to 50 L of PCR buffer containing 20 mM MgCl2, 2.5 
g/L bovine serum albumin (BSA), and 500 mM Tris (pH 8.3). Plasmid DNA was digested by adding 
10 units of the restriction enzyme HindIII (New England BioLabs, Ipswich, MA) to each dilution 
mixture and incubating for 24 hours at 37C. The restriction enzyme was then inactivated at 65C for 1 
hour.
The PCR mixture comprised plasmid DNA, ranging from 6 x 106 to 6 x 100 copies/L, as the 
template, 0.5 M of each primer, 200 M of each deoxynucleotide triphosphate (dNTP), 0.04 U/L of 
KlenTaq1 polymerase (AB Peptides, St. Louis, MO), 6.4 ng/L of Anti-Taq Monoclonal Antibody 
(eENZYME, Montgomery Village, MD), 2 mM MgCl2, and 1X LCGreen Plus (Idaho Technology, Salt 
Lake City, UT) in 50 mM Tris (pH 8.3), 500 ng/L BSA, and 3.75% polyvinylpyrrolidone (PVP) (Av. 
Mol. Wt. 360,000, Sigma-Aldrich Corporation, St. Louis, MO). 
Thermocycling
Figure S2 provides a photograph and scheme of the custom instrument. A 0.04” gauge J-type 
thermocouple (Omega, Stamford, CT) was used for temperature monitoring. The signal from the 
thermocouple was amplified and linearized (AD594, Analog Devices, Norwood, MA) and the output 
was connected through a shielded I/O connector block (SCB-68, National Instruments) to a PCI-MIO-
16XE-10 DAQ card.  The temperature measurement was calibrated to the inside of the disk using DNA 
standards of known melting temperatures: complementary synthetic oligonucleotides at 62C, and PCR 
products at 79.5C, and 92C. The disk was spun using a servo motor (200627, Maxon Precision 




The fluorimeter consisted of light from a 465 nm blue LED passed through a 475 DF30 bandpass 
filter and dichroic beam splitter and was then focused with a glass asphere lens onto the disk.  Emitted 
light was collected through this same lens and reflected 90 by the dichroic beam splitter 505DRSP.  
This light was reflected 90 by a 540DRLP dichroic beam splitter, passed through a 524 DF20 bandpass 
filter and detected with an OPT301M photodiode (Burr-Brown, Tuscon, AZ) for real-time fluorescence 
monitoring during PCR. A scheme of the fluorimeter is seen in Figure S3. The output from the 
fluorimeter was connected to the same I/O connector block as the thermocouple and LabView 7.1 
(National Instruments) was used to analyze the temperature and fluorescence data at a frequency of 1 
kHz.
Disk Imaging and Analysis
A 455 nm blue LED was positioned 120 mm below the disk with an excitation filter of 438 DF20. 
The emitted fluorescent light from the disk was collected with a lens (Ultrasonic EF 20mm 1:2.8, 
Canon, Tokyo, Japan) positioned 260 mm above the disk. This collected light then passed through a 483 
DF32 bandpass filter and was imaged with a CCD camera (iXon, Andor Technology, South Windsor, 
CT), as seen in Figure S4. Andor iXon software vs. 4.0 (Andor Technology) was used to take a 15 
second exposure background subtraction image followed by a 15 second exposure. The image threshold 
was set from 0-5000, saved as a jpg file, and imported into ImageJ for analysis.  
3
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FIGURES (SUPPORTING INFORMATION) 
Figure S1. A photograph of a small section of the disk is shown with wells filled with PCR mixture and 
the channel filled with mineral oil dyed with Oil Red O. 
4
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Figure S2. (Top) A photograph of the rapid air thermocycler is shown with: (1) servo motor, (2) 
fluorimeter, (3) temperature profile input keypad and display, and (4) air chamber for disk 
thermocycling. (Bottom) A scheme is shown of the spinning disk platform. 
5
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Figure S5. Real-time PCR data is presented for each dilution test within the spinning disk platform, 
reporting the normalized fluorescence value for each cycle. Concentrations are provided in plasmid 
copies per well. 
8
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 CHAPTER 6 
 
 
QUASI-DIGITAL PCR: ENRICHMENT AND QUANTIFICATION                             
 





A previously described spinning disk platform with 1000 unique wells was 
utilized with a technique we call quasi-digital PCR, in which at most one rare mutation is 
preferentially amplified in a reaction well that also contains multiple wild-type 
background templates, for enhanced mutation enrichment and quantification. The allele-
specific PCR technique of allele-specific competitive blocker-PCR (ACB-PCR) provided 
preferential amplification of the mutation. A CCD camera acquired a fluorescent image 
of each disk following PCR, and the well intensity frequency distribution and Poisson 
distribution statistics were used to count the positive wells and to determine the number 
of template molecules amplified on the disk. A 111 bp genomic DNA product was 
amplified within the disk and analyzed in about one hour, with PCR cycle times of 23 s. 
Two separate dilution series were compared to validate that this quasi-digital PCR 
technique did suppress wild-type template amplification. A detection sensitivity of 0.01% 
was determined by this method, detecting 42 mutation template molecules amongst 
450000 wild-type template molecules, and the number of positive reactions compared 
well with absorbance measurements. The spinning disk platform reduces disposable cost, 
instrument complexity, and thermocycling time and the ACB-PCR chemistry improve
sensitivity and lowers assay cost over previously described methods. This technique has 
application in detecting and quantifying rare event mutations including from circulating 




The discovery of circulating tumor cells (CTCs) in peripheral blood was first 
made in 1869 by T.R. Ashworth (Ashworth 1869). Detection of these CTCs has the 
potential to provide a noninvasive, sensitive technique to detect cancer earlier and 
provide information for proper therapy selection and drug resistance. Thus, there is a 
significant ongoing effort to be able to detect and quantify CTCs, as well as understand 
the genetic mutations associated with them. The main challenge in identifying, 
quantifying, or collecting CTCs is that CTC concentrations can be as low as one cell in 
one ml of blood (Nagrath et al. 2007), or one tumor cell per 105 - 107 peripheral blood 
mononuclear cells (Ross et al. 1993), making it difficult to detect and quantify the cancer 
cells with current techniques. Enrichment approaches have been applied in order to 
overcome the difficulties associated with such low concentrations such as filtration (Vona 
et al. 2000), density gradient (Müller et al. 2005), flow cytometry (Cruz et al. 2005), and 
immunomagnetic enrichment techniques (Allard et al. 2004). However, these methods 
can suffer from low specificity, low sensitivity, a loss of CTCs, or false negatives and 
positives (Alunni-Fabbroni and Sandri 2010). Thus, there remains a need for a rapid, 
sensitive, specific and repeatable method for detecting and quantifying CTCs. 
PCR based techniques have overcome some of these sensitivity and specificity 
issues. One such technology that has improved sensitivity is the technology BEAMing 
(beads, emulsion, amplification and magnetics), finding mutated circulating free DNA at 
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a detection rate as low as 0.18% of all circulating free DNA in plasma of colorectal 
cancer patients (Diehl et. al 2008; Dressman et. al 2005). Another PCR technique used is 
the amplification refractory mutation system (ARMS) PCR (Newton et al. 1989), 
providing allele specific amplification. This technique implements a primer with a 
terminal 3’-nucleotide that is allele specific.  Therefore, one can design this primer to 
match the mutant template and be refractory to the wild-type, thus delaying the 
mismatch’s PCR. To further improve on the ARMS primer design, allele-specific 
competitive blocker-polymerase chain reaction (ACB-PCR) has been introduced (Orou et 
al. 1995), providing a ‘double kill’ methodology to preferentially amplify the mutant 
template. A probe is designed to match the template to be suppressed during PCR. 
Therefore, the mismatched ARMS primer competes with the probe to anneal to the 
template. This method greatly delays PCR of the mismatch but also delays the Cq of the 
matched template.   
Digital PCR (Vogelstein and Kinzler 1999) uses limiting dilution or volume to 
detect minor fractions of mutated DNA by having only one DNA template in a given 
reaction volume. Once amplified, the reaction volumes are fluorescently analyzed; 
relying on binary positive/negative calls (Ottesen et al. 2006; Warren et al. 2006).  A 
variation on this method has been implemented, which we call quasi-digital PCR, 
combining the amplification refractory mutation system (ARMS) PCR, a scorpion primer 
and digital PCR, achieving a detection rate as low as 0.02% (Wang et al. 2010), to 
selectively amplify the mutation allele. We term this method as quasi-digital because 
each well is loaded with multiple copies of wild-type DNA but contains at most only one 
copy of the mutation. Parallel reactions occur simultaneously followed by fluorescence 
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detection to determine how many reactions contain a mutation copy, counting the 
mutations digitally, for improved quantification over real-time PCR methods. 
Furthermore, by running multiple reactions one can theoretically improve on the 
sensitivity of the method by orders of magnitude, depending on the number of reactions 
performed. 
The focus of this work is to achieve a more rapid, less expensive process for 
quasi-digital PCR with capabilities for lower limits of detection by implementing ACB-
PCR, using an ARMS primer and molecular beacon probe, rapid air thermocycling, and 
1000 individual nanoliter-sized reactions using a previously described spinning disk 
platform (Sundberg et al. 2010). The goal is to detect one tumor cell per 105 - 107 
background cells, to make detection and quantification of tumor cells from a blood 
sample more straightforward.  Towards this goal, this work uses the mutation T1796A 
BRAF, a known mutation site prevalent in malignant melanomas (Yazdi et al. 2003) and 
papillary thyroid cancer (Xing et al. 2004) and can also be found within other cancers 
(Davies et al. 2002). The mutation target was mixed with a large background of wild-type 
DNA to demonstrate the feasibility of counting CTCs using the proposed method. 
 
Methods and Procedures 
 
Disk Design and Manufacturing 
 
The digital PCR disk design utilizes centrifugal force to move fluid from a 
loading reservoir, located near the center of the disk, along a spiral channel and fill 1000 
individual square wells that are facing radially outward from the channel. The spiral 
channel is 250 μm wide and each well has dimensions of 500 μm x 500 μm x 125 μm, or 
a 30 nL volume. This design is fabricated from thin film plastics to create an inexpensive 
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disposable and requires only centrifugation for fluid control. The entire disk is 120 mm in 
diameter, the size of a CD, and is 375 μm thick (see Figure 6.1). The prototyping method 
of xurography (Bartholomeusz et. al 2005) was used to pattern the channel layer disks. 
Briefly described, the microchannel is patterned with SolidWorks® (Concord, MA), 
imported into Adobe Illustrator® (Adobe, San Jose, CA) and exported to a cutting plotter 
(CE5000-60, Graphtec, Santa Ana, CA). An FR83-Black polycarbonate thin film sheet, 
125 μm thick, (Sabic Polymershapes, Fresno, CA) was patterned with the loading 
reservoir, spiral channel and 1000 wells. This sheet was then thermally bonded between 
two other FR83-Clear polycarbonate thin film sheets (Sabic Polymershapes) of the same 
thickness, laminating the plastic layers together at 175°C for 2 min using a JetPress 14 
heat press (Geo Knight, Brockton, MA). Two 500 μm thick Teflon strips (Scientific 
Commodities Incorporated, Lake Havasu City, AZ) were inserted into the loading 
reservoir, allowing larger loading volumes, and a pin-sized hole was created at the end of 




ACB-PCR utilizes a ‘double kill’ technique to preferentially amplify the mutation 
allele by utilizing an ARMS primer that matches the mutation allele while refractory to 
wild-type and a probe designed to match the wild-type to further inhibit primer annealing 
on the wild-type allele (Figure 6.2). The forward primer 5’ GTGATTTTGGT-
CTAGCTACAGA 3’ and reverse primer 5’ TCAGTGGAAAAATAGCCTCAATTC 3’ 
were designed to amplify a 111 bp product from the mutant allele. The competitive 
blocker probe used was molecular beacon probe 5’ FAM-CGGTCTAGCTAC-
AGTGAAATCTCGACCG–BHQ 3’ (Biosearch Technologies, Novato, CA). The bolded 
68
nucleotides in the forward primer and molecular beacon probe sequences represent the 





Figure 6.1. Disk design shown to scale. The disk consists of a loading reservoir, spiral 
microchannel with 1000 wells facing radially outward along the channel, and an overflow 










Wild-type human genomic DNA was extracted from human blood and the BRAF 
homozygous mutation was obtained from the ATCC as purified DNA (HTB-72D, 
American Type Culture Collection, Manassas, VA). The concentrations of genomic DNA 
were determined by absorbance at 260 nm (A260), assuming an A260 of 1.0 is 50 mg/L.  
The PCR mixture comprised BRAF mutation DNA, ranging from 0.5 to 0.005 
ng/μL, as the template with 1 μM reverse primer, 0.2 μM forward primer, 0.5 μM 
molecular beacon probe, 200 μM of each deoxynucleotide triphosphate (dNTP), 0.04 
U/μL of KlenTaq1 polymerase (AB Peptides, St. Louis, MO), 6.4 ng/μL of Anti-Taq 
Monoclonal Antibody (eENZYME, Montgomery Village, MD), 2 mM MgCl2, and 1X 
LCGreen Plus (Idaho Technology, Salt Lake City, UT) in 50 mM Tris (pH 8.3), 500 
ng/μL BSA, and 2.5% polyvinylpyrrolidone (PVP) (Av. Mol. Wt. 360,000, Sigma-
Aldrich Corporation, St. Louis, MO). Tests involving a mixture of mutation and wild-
type DNA also contained 50 ng/μL wild-type DNA. 
Forty μL of PCR mix and 100 μL of mineral oil (M5904, Sigma-Aldrich 
Corporation), dyed with 1 mg/mL Oil Red O (Matheson Coleman & Bell, Gardena, CA), 
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were pipetted into the disk loading reservoir. Two polycarbonate disks, 750 μm thick 
with an outer diameter of 75 mm, were then coupled to each side of the disk. The disk 
was spun for 5 min at 4500 rpm to load each of the wells along the spiral channel path 
and to fill the channel with mineral oil. The end of the spiral channel was then thermally 




The disk rapid air thermocycling instrument has been described previously 
(Wittwer et al. 1997; Sundberg et al. 2010). For disks containing only mutation template, 
100 cycles of 50°C annealing for 0 s, 72°C extension for 2 s, and 95°C denaturing for 0 s 
was achieved in about 45 min while spinning the disk at 4500 rpm (27 s/cycle). The 
annealing temperature was raised for disks that contained mutation template with wild-
type background to prevent wild-type amplification, with 100 cycles of 55°C annealing 
for 0 s, 72°C extension for 2 s, and 95°C denaturing for 0 s in about 38 min (23 s/cycle).  
 
Disk Imaging and Analysis 
 
The disk was fluorescently imaged following PCR for digital well analysis using the set-
up shown in Figure 6.3. This consisted of a 470 nm blue LED positioned 70 mm below 
the disk with an excitation filter of 469 DF35 (FF01-469/35-25, Semrock, Rochester, 
NY). The excitation light source was mounted on a turntable with the LED located 45 
mm from its center. This turntable was rotated by a stepper motor (PK266-01A, Oriental 
Motor, Torrance, CA) controlled using an MID 7604 motor driver and PCI 7330 card 
(National Instruments, Austin, TX). The excitation light was rotated one 
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Figure 6.3. A scheme is shown of the disk imaging set-up.  
 
revolution during imaging at a velocity of 10 rpm to achieve more uniform excitation 
over all of the wells within the disk. The emitted fluorescent light from the disk wells was 
collected with a lens (Ultrasonic EF 20mm 1:2.8, Canon, Tokyo, Japan) positioned 350 
mm above the center of the disk. This collected light then passed through a 525 DF20 
bandpass filter (FF01-525/20-25, Semrock) and was imaged with a CCD camera (iXon, 
Andor Technology, South Windsor, CT) cooled to -20 °C. Andor iXon software vs. 4.0 
(Andor Technology) was used to take a 45 s exposure background subtraction image 
followed by a 45 s exposure. The image threshold was set from 0- 2500, saved as a jpg 
file, and imported into ImageJ (Rasband 1997) for analysis. This software was then used 
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to threshold, size exclude, and create histograms of well intensity for each disk image. 
The threshold and minimum pixel number was operator defined. Histogram frequency 
distributions were then used to determine the number of positive and negative wells for 
each test with normal distribution curves fitted to the histogram data using Minitab 15 
statistical software (Minitab, State College, PA). The intersection of the two normal 
distribution fitted curves determined the cut-off point for positive and negative calls. 
 
Results and Discussion 
 
Quasi-digital PCR quantification results with rapid PCR thermocycling were 
provided in about an hour. Thermocycle times (23 s cycles) were much faster than 
reported from the recently published ARMS-scorpion PCR technique (>90 s cycles), 
which also requires a 10 min hot start time. Although our technique required twice as 
many cycles the total PCR time was still less than half the time required with the ARMS-
scorpion assay. Furthermore, by eliminating scorpion primers assay costs have been 
reduced. 
A dilution series was performed with only the BRAF mutation DNA in order to 
demonstrate PCR within the spinning disk, as seen in Figure 6.4. The dilution series 
ranged from 0.5 to 0.005 ng/μL, or about 4.5 to 0.045 copies/well. A dilution series was 
then performed with the BRAF mutation DNA within a larger wild-type background. The 
BRAF mutation concentration again ranged from 0.5 to 0.005 ng/μL while the wild-type 
background was held constant at 50 ng/μL or about 450 copies/well, as seen in Figure 
6.5. The ACB-PCR chemistry effectively suppressed wild-type amplification, by 
comparing the two dilution series and obtaining similar positive well results for mutation 
copy concentration. For example, mutation template with a concentration of 0.45 
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copies/well had 384 positive wells as compared to mutation template with wild-type 
background results where an average of 405 positive wells were found with a standard 
deviation of 18 positive wells across three individual tests. It is seen in Figures 6.4 and 
6.5 that well intensity distributions of the different panels drifts. This is due to the user-
defined brightness and contrast, and threshold settings of the fluorescent images, which 
varied during analysis. Table 6.1 provides the number of positive wells within each disk 
as well as the number of copies amplified for each dilution series. The number of copies 
amplified was statistically determined from the Poisson distribution, as described 
previously (Sundberg et al. 2010), but has also taken into consideration the probability of 
having more than two through ten copies present in a well, not simply the probability of 
having more than one copy in a well, to provide a more accurate approximation. The 
number of DNA template copies amplified based on statistical analysis correlates well 
with the absorption measurements taken from the DNA samples prior to testing. 
A detection sensitivity of 0.01% was calculated based on an average of 43 
mutation copies among 450000 wild-type copies across three individual tests. This 
sensitivity is a slight improvement over the previously published quasi-digital PCR work, 
although the background copy number used in this study was nearly three orders of 
magnitude greater per well (450 copies/well compared to 6-7 copies/well). The histogram 
distribution detection scheme with this work currently prevents further detection 
sensitivity. Disk imaging could be improved for more uniform fluorescence excitation 
across the entire disk’s well array to provide better separation between the positive and 
negative distributions, allowing for a more sensitive thresholding implementation. If the 
fluorescence detection was improved for higher “on/off” resolution one could
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 Figure 6.4. Fluorescent images are presented for a dilution series of BRAF mutation 
DNA concentration ranging from about 4.5 – 0.045 copies/well. Histogram data 
corresponding to each image is also presented; including frequency distribution, normal 


















 Figure 6.5. Fluorescent images are presented for a dilution series of BRAF mutation with 
wild-type background, mutation DNA concentration ranging from about 4.5 – 0.045 
copies/well and 450 copies/well of wild-type DNA. Histogram data corresponding to 
each image is also presented; including frequency distribution, normal distribution fit 
curves, the mean, and standard deviation. 
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Mutation Template with 450 CopiesJWell 
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Table 6.1. Number of positive wells and number of copies amplified for two template 
dilution series on the spinning PCR disk. Tests involving background wild-type DNA and 
within the digital range were run in triplicate. The average and standard deviation are 
shown in this table for these repeat tests. 
 
DNA
Concentration Number of Wells Number of Copies Number of Wells Number of Copies
(Copies/Well) Amplified Amplified* Amplified Amplified*
4.5 992 N/A 996 N/A
0.45 384 423 405 ± 18 452 ± 26
0.045 42 42 43 ± 8 43 ± 8
*Determined using Poisson distribution statistics
Mutation Template




theoretically achieve a detection sensitivity of 0.0002%, using the current chemistry and 
well configuration, by simply diluting the mutation sample to detect 1 copy amongst the 
same wild-type background.  
Not all wells fluoresced with the highest mutation concentrations of the dilution 
series, with a few wells either failing or being negative in each case. One of the causes 
for this occurrence is the manufacturing process.  The cutting plotter on rare occasion 
creates a ridge next to a well, causing irregular fluid flow, allowing mineral oil to fill the 
well rather than the PCR mix. These wells are easily detected within the fluorescent 
image due to a much lower fluorescent signal than a negative well’s fluorescent signal. 
More consistent and accurate manufacturing methods need to be investigated in order to 
eliminate this issue. Another cause of obtaining a negative well with the highest 
concentration is the low probability of having zero mutation copies in a well. The Poisson 
distribution approximation calculates that with an average concentration of 4.5 copies per 
well there is approximately a 1% chance that a well would not have any mutation DNA 
present. 
T1796A BRAF mutation DNA was successfully amplified and analyzed within 
the spinning disk with and without 450 wild-type background copies per well in about an 
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hour. Future work will aim to improve disk manufacturing, thermocycling rates, 
fluorescence interrogation of the disk’s well array, and ease of data analysis. Additional 
oncogene mutation targets will also be investigated. These improvements should allow us 
to reach the goal of having adequate sensitivity for detection and quantification of CTCs 
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DIGITAL PCR STATISTICS 
 
 
In order to validate digital PCR results it is important to have a standard with 
which to compare results and also to understand the statistical significance of each test. 
Specific statistics of importance in this work are, 1) the probability that more than one 
DNA copy is in a well, 2) accurate estimation of the average copy number per positive 
well, and 3) the statistical confidence one has in a given result. This chapter utilizes the 
Poisson distribution to address the first two areas and applies the Wilson score interval to 
the third area. These statistical methods also apply to the quasi-digital PCR approach 
presented in Chapter 6 with the exception that on/off results represent mutation DNA 
copies only. 
 
DNA Concentration Standards 
 
To properly validate our digital PCR tests we must have a standard with which to 
compare our results. Absorption at 260 nm (A260) was used to measure genomic DNA 
and plasmid DNA concentrations, due to the fact that nucleic acids have an absorption 
maximum at this UV wavelength. The subsequent paragraphs explain how the absorption 
measurement is used to determine the number of copies per microliter.  
In Chapter 5 the plasmid DNA stock concentration was determined using the 
following relationships and Equations 7.1-7.4 based on absorption at A260: 
• The number of base pairs (bp) within the plasmid DNA is 3686  
• 1 A260 = 50 μg/ml for a 10 mm path 
• 6.02 x 10^23 copies/mol = 6.02 x 10^17 copies/μmol 
• The average molecular weight (MW) of a base is 330 μg/μmol (multiply by 2 to 







































copies 16260 1001.3 ×=μ         (7.2) 
 
 





copies ×=μ         (7.4) 
 
 
Similar calculations were made for human genomic DNA in Chapter 6 to 
determine that one copy is approximately 3.3 pg.  At the common concentration of 5 
ng/μl, as determined by A260 absorption, used with PCR within our lab there are 
approximately 1500 copies/μl.  At this concentration there would be 1.5 copies in a 1 nl 
well.  Dilution of DNA is necessary to lower the concentration to allow wells to be 30 nl 
in size. For example, diluting the initial DNA concentration 100 times (~15 copies/μl) 





The Poisson distribution is used to determine what DNA concentration should be 
used to limit the probability of having more than one DNA molecule in a given well, or in 
the case of quasi-digital PCR, the probability of having more than one mutation DNA 
molecule in a given well, as seen in Equation 7.5, where λ is the mean number of DNA 
copies per well and k is the number of DNA copies of interest per well (i.e., 1, 2, 3, 4, etc. 
copies that may be present in a given well).  Therefore, if 67% of the wells are negative 
then the expected number of DNA copies per well would be –ln 0.67 or 0.40 (the λ value 
solved when Pk(0) = 0.67 and k = 0).  The probability that a positive chamber contains 
more than one DNA template would be 1-0.67-((e-0.40)*(0.401))/(1!) or 6.2%.  One must 
also take into consideration the probability of having more than 2, 3, 4, 5, etc. copies of 
DNA in a positive well to obtain a more accurate approximation. This can be done by the 
summing of Poisson distributions. Thus, the probability that a positive well contains more 
than two DNA templates would be 1-0.67-((e-0.40)*(0.401))/(1!)-((e-0.40)*(0.402))/(2!) or 
0.82%. The probabilities for each case are then summed together and used to determine 
the total number of DNA templates present. For the case of having 67% of the wells 
being negative, a probability summation of 7.2% is calculated, which for 1000 wells 
would represent 357 DNA molecules that have been amplified by PCR. Figure 7.1 
provides a graphical representation of Poisson distributions, showing the average number 
of copies/positive well as a function of the proportion of positive wells. It is seen that as 
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Figure 7.1. Plot shows the average number of copies/positive well as a function of the 
proportion of positive wells, determined by Poisson distributions. This plot considers the 
probability of having more than one through more than 10 DNA templates in a given 





In this section confidence intervals of sample proportions to estimate the 
population proportion are constructed.  The confidence interval calculations assume that 
the data are binary, the probability of success is the same for each trial, and the trials are 
statistically independent.  The population proportion is symbolized p and the point 
estimate of the population proportion, or sample proportion, is symbolized by p-hat.  The 
standard error of a sample proportion is the estimated standard deviation of a sampling 
distribution.  The exact standard error of a sample proportion is given in Equation 7.6, 
where p is the population proportion and n is the sample size. 
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The typical estimated standard error is known as the Wald interval (Wald and 
Wolfowitz 1939).  The number of successes and the number of failures must be at least 5 
each and this approximation does not work well when p is the near the boundaries, either 
near 0 or 1.  In fact, it has been found that even when p is not near the boundaries erratic 
behavior can occur (Agresti and Coull 1998).  Although this method represents a simple 
solution to solving the confidence interval it is typically inadequate, especially for digital 
PCR applications where many of the solutions involve p near the boundaries. 
The Wilson score interval (Wilson 1927) provides more accurate results, 
especially for smaller sample sizes and proportions close to 0 and 1 (Brown et al. 2001).  
The Wilson score interval is calculated according to Equation 7.8, where z1-α/2 is the 1-
α/2 percentile of a standard normal distribution. For example, for a 95% confidence 
interval let α = 0.05 and so z1-α/2 = 1.96. The center of the Wilson score interval 

























































          (7.9) 
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The reader should note that the sample size represents the number of DNA copies 
present, not the number of wells of the disk.  The type of sample and genetic mutation 
being tested will determine what sample proportion is needed and also determine the 
confidence level desired for that sample proportion.  
 
Applying the Wilson Score Interval 
 
An example applicable to quasi-digital PCR is presented in Figure 7.2 utilizing 
the Wilson score method. Three confidence levels of 90%, 95% and 99% are applied to 
calculate the Wilson score interval for one million DNA copies with mutation population 
proportions being 0.01% (100 mutation copies), 0.001% (10 mutation copies), 0.0001% 
(1 mutation copy), and 0.00001% (0.1 mutation copy). It is noted that erratic behavior 
occurs with this method when approaching one mutant DNA copy. Table 7.1 illustrates in 
more detail this behavior as the proportion approaches zero for a 95% confidence level 
with populations of 105, 106, and 107 DNA copies. This error is introduced due to 
rounding error when applying a two-sided interval at the boundary. In 2001, Brown et al. 
described a modified Wilson score interval to diminish this error, wherein a one-sided 
Poisson approximation is applied for the lower or upper bound when approaching very 
near the boundaries. However, with the very low mutation population proportions of 
interest with quasi-digital PCR even this method provides only modest improvement. 
One must be cautious with statistical analysis of results that approach detection of one 
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Figure 7.2. Wilson score centers with error bars representing Wilson score intervals are 
























Table 7.1. Wilson score centers and intervals for a 95% confidence level are shown at 
varying DNA copy numbers and mutation population proportions.  
 
No. of Mutation Wilson Score Wilson Score
DNA Copies Pop. Proportion No. Mutated DNA Center Interval
[No. Mutated DNA] [No. Mutated DNA]
1.E+05 5% 5000 5001.73 ± 135.09
1.E+05 1% 1000 1001.88 ± 61.70
1.E+05 0.1% 100 101.92 ± 19.68
1.E+05 0.01% 10 11.92 ± 6.49
1.E+05 0.001% 1 2.92 ± 2.74
1.E+05 0.0001% 0.1 2.02 ± 2.02
1.E+05 0.00001% 0.01 1.93 ± 1.93
1.E+06 5% 50000 50001.73 ± 427.17
1.E+06 1% 10000 10001.88 ± 195.03
1.E+06 0.1% 1000 1001.92 ± 61.98
1.E+06 0.01% 100 101.92 ± 19.69
1.E+06 0.001% 10 11.92 ± 6.49
1.E+06 0.0001% 1 2.92 ± 2.74
1.E+06 0.00001% 0.1 2.02 ± 2.02
1.E+07 5% 500000 500001.73 ± 1350.84
1.E+07 1% 100000 100001.88 ± 616.70
1.E+07 0.1% 10000 10001.92 ± 195.91
1.E+07 0.01% 1000 1001.92 ± 62.01
1.E+07 0.001% 100 101.92 ± 19.69
1.E+07 0.0001% 10 11.92 ± 6.49






Quasi-Digital PCR Statistics Example 
By way of example consider a quasi-digital PCR experiment with 1000 wells 
containing an average concentration of 500 DNA copies/well for a total of 500000 DNA 
copies. Following PCR 190 wells are found to be positive, due to at least one mutation 
copy being present in each of these positive wells. Since more than one copy of DNA 
may be present in a well the Poisson distribution approximation is applied to determine 
that approximately 194 mutation copies have actually been amplified within the wells of 
the disk, due to a calculated 2.07% increase of DNA copies. Therefore, the mutation 
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population proportion is 0.0388%, which yields 196 ± 27 DNA copies at a 95% 




A set of equations for computing DNA concentrations from absorption 
measurements has been provided. This allows one to use standards to validate digital 
PCR results. The Poisson distribution approximation shows that as DNA template 
concentration increases the average number of copies per positive well increases. The 
Wilson score method provides additional information as to what window, or interval, of 
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Several key scientific contributions have been made by the author in the 
furthering of nucleic acid identification and quantification by miniaturizing and 
simplifying current molecular diagnostic techniques. These contributions have ultimately 
resulted in a platform capable of performing digital PCR accurately using relatively 
simple and rapid methods. A brief summary of the scientific contributions and 




This dissertation makes contributions and draws conclusions within the following 
areas: 
 
• Miniaturization of DNA melting analysis. DNA melting analysis has been 
miniaturized to nanoliter-sized interrogation volumes. While the reaction volume 
was reduced three orders of magnitude the signal-to-noise ratio was only reduced 1.5 
orders of magnitude, which still provided sufficient signal for accurate genotyping 
and scanning. The 20 data points collected per degree Celsius does not qualify this 
method as high resolution melting analysis but does provide sufficient data points 
for genotyping and scanning of many targets. This reduction in interrogation volume 
provides evidence that less reagent consumption and DNA starting template and 
more parallelization is possible with melting analysis for a more rapid, inexpensive, 
high-throughput solution that requires no separations, processing or labeled probes.  
• Xurography rapid prototyping development. Advancements were made within 
rapid prototyping to further develop the method of xurography. This provides a 
rapid, inexpensive technique to quickly design and manufacture microfluidic chips 
and disks for research purposes. It was found that tape-bonded microchannels do 
have a shorter life span than the traditional glass-bonded microchannels but are an 
order of magnitude less expensive and four times faster to make for prototyping 
purposes. Knife plotter resolution was also found to be sufficient for patterning the 
digital PCR disks with its array of 1000 wells. 
• New method for fluid partitioning. Our spinning disk design reduces disposable 
and instrument costs by requiring minimal fluid control, relying on centrifugation 
rather than valves, pumps or microdroplet dispensers. The disk consists of three 
inexpensive plastic thin film sheets laminated together with an architecture that 
passively divides a spun sample into a thousand compartments.  
• Spinning Disk Platform for Microfluidic Digital PCR. A novel disk platform 
was developed that quickly and easily partitions a DNA sample and quantifies the 
number of DNA templates present in the sample by digital PCR. This method 
further allows rapid air thermocycling to be used for much quicker PCR turnaround 
times than is currently available, with cycle times as fast as 23 s/cycle. Following 
PCR, each compartment is interrogated for a positive/negative signal by 
fluorescence imaging. Furthermore, aggregate real-time PCR and DNA melting 
analysis data are provided for amplicon and assay validation. Although the melting 
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curve Tm standard deviation between runs is larger than preferred for genotyping it 
still provides product specificity evidence that the region of interest has been 
amplified rather than nonspecific amplification. 
•     Quasi-digital PCR method. The concept of digital PCR was taken one step 
further by using a quasi-digital PCR method. This allows one to load each well with 
large amounts of background wild-type DNA and preferentially amplifying rare 
event mutation DNA template using the allele-specific chemistry of ACB-PCR. This 
method reduces cost and improves sensitivity (0.01%) over a previously described 
quasi-digital PCR method, and offers higher quantification accuracy than most 
analog quantification methods. 
• Statistic analysis tools for digital PCR. Statistic tools have been developed to 
more completely determine digital PCR results based on the Poisson distribution and 
Wilson score method to calculate confidence intervals. 
• Additive protocol for improved PCR. It was found that adding 2.5-3.75% 
polyvinylpyrrolidone (PVP) into the PCR mix greatly improved results within the 
digital PCR disks. PVP has a high affinity for polycarbonate and PETG and is able 
to adsorb to the plastic walls of the microchannel, effectively competing with and 
preventing other PCR mix components from adsorbing to the plastic due to surface 
chemistry effects. 
• Published works. Three manuscripts have been published from this work, with a 
fourth manuscript in process of being submitted. A book chapter involving low-cost 
manufacturing techniques was also published. These publications are as follows: 
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2. Greer J, Sundberg SO, Wittwer CT and Gale BK. Comparison of glass 
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Improve Digital PCR Platform Instrumentation 
 
Future instrumentation can be improved to be more user-friendly and reduce 
analysis and thermocycling times while also lowering instrument cost. A fluorescent 
scanner is envisioned to replace disk imaging following PCR to provide higher “on/off” 
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fluorescence resolution and further reduce instrumentation cost by simplifying the optics. 
The thermocycler can also be better fitted to the disk for faster thermocycling rates. 
Melting analysis on individual wells may be explored as well. The next prototype version 
will aid in commercialization of this platform to further digital PCR research. 
 
Improve Spinning Disk and Explore New Configurations 
 
The cutting plotter occasionally creates undesirable ridges next to a well, causing 
irregular fluid flow and allowing mineral oil to fill the well rather than PCR mix. 
Improved manufacturing methods need to be investigated for more controlled and 
consistent well dimensions within the disk. Configurations should also be designed and 
manufactured to handle multiple samples within a disk, rather than single sample use. 
Varying volumes and numbers of wells for quasi-digital PCR can also be investigated to 
determine if different configurations can lower limits of detection than is currently 
possible. 
 
Investigate Other Digital PCR Applications 
 
Other applications of digital PCR should be investigated aside from rare event 
oncogene mutation quantification. Multi-color probe assays can be designed for ratio 
quantification of wild-type to mutation template for gene expression analysis. Viral load 
quantification assays could be designed for targets such as HIV. Haplotyping for 
determining if combinations of mutations are in cis or trans with each other can also be 
clinically useful. This data could be obtained by multiplex DNA melting analysis with 
digital PCR reactions. Noninvasive prenatal testing of targets such as trisomy 21 could 
also be explored. 
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